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ABSTRACT
SYNTHETIC AND MECHANISTIC INVESTIGATIONS OF SUPERELECTROPHILIC
REACTIONS

Kenneth Nicholas Boblak, Ph.D.
Department of Chemistry and Biochemistry
Northern Illinois University, 2014
Douglas A. Klumpp, Director
This dissertation describes various intramolecular cyclizations promoted by
superacid. The first chapter deals with the formation of N-heterocyclic indenes. In these
reactions protonated N-heterocyclic rings are shown to enhance the reactivity of the
carboxonium electrophile for the cyclodehydration of various ketones. The second chapter
explores an unusual regioelectronic effect that controls whether Markovnikov or conjugate
addition takes place across a double bond. The addition facilitated by superacid depends on
the position of olefin functionality on N-heterocyclic olefinic derivatives. The final chapter
investigates highly stable superelectrophilic systems and the trapping of their carbocations to
highly functionalized fluorenes. This study includes the direct observation of dicationic and
tricationic reactive intermediates in magic acid media via low temperature, nuclear magnetic
resonance spectroscopy.

The superelectrophilic cores promote charge-charge repulsion

enhancing anti-aromaticity of the polycyclic-fluorene protons.
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CHAPTER 1

INTRODUCTION

1. Superacids
A superacid is a medium having a high acidity, generally greater than 100% sulfuric
acid. The term superacid first appeared in the literature in 1927. 1 However, it was not until
1968 that a general definition of such strong acids was made. Gillespi set the benchmark for
a superacid as that of a medium having a high acidity, generally greater than 100% sulfuric
acid.2

He states, “The acidity of fluorosulfonic acid can be considerably increased by the

addition of SbF5 and SbF5-SO8, and the resulting solutions are the most highly acidic media
known at the present time. These systems may therefore be justifiably called superacid
media. In particular they are considerably more acidic than 100% sulfuric acid.”2 In 1979,
Olah and Prakash defined Lewis superacids as those stronger than pure aluminum chloride in
Science.3 Therein, Professor Olah discusses the remarkable usefulness of superacid media in
the preparation of stable, electron-deficient carbocations and their ability to achieve
previously unattainable hydrocarbon transformations.3

His premonition that superacid

chemistry would open up new fields in chemistry has certainly proved true. Professor Olah
received the Nobel Prize in chemistry in 1992 for his lifelong contributions to carbocation
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chemistry. As time has gone by, these early and general definitions of superacid media still
apply for strong Brønsted acids. However, since 100% sulfuric acid tips the pH scale at the
low end, a problem arises in using it when measuring stronger acids. Because the definition
of the pH scale in terms of hydrogen ion concentration is restricted by dilute aqueous
solutions in the pH range of 0-14,4 it was necessary to develop a scale for non-aqueous,
concentrated, Brønsted superacids. To remedy the problem the Hammett acidity scale was
developed. The Acidity of any solution on the Ho scale is determined by the amount of
neutral indicator that has been converted to a protonated species by a Brønsted acid.5
Brønsted acids span the Hammett acidity scale (Figure 1.1) from Ho -12 for anhydrous
H2SO4 to Ho -30 for HF-SbF5 (1:1).6 The superacid used primarily in the research described
below is commonly known as triflic acid (TfOH) and has and Ho value of -14.1. Magic acid
(FSO3H-SbF5, 4:1) is also used and, from the scale below, has a Ho value around -26.
Superacids have the capability of interacting with the weak base sites of functional groups on
molecules in solution and even solution molecules themselves. Therefore, there has been
some debate over the consistency of the Hammett acidity scale especially when a variety of
indicators have been used.5 Other acidity scales have been developed in the hopes of
achieving a absolute, unified acidity scale.7-9 Still, the Hammett acidity scale remains the
primary scale for quantifying superacidity. Despite any quantitative ambiguities, superacidic
media has a remarkable ability to assist in organic transformations that are impossible in
more weakly acidic media.

3

Figure 1.1: The Hammett Acidity Scale
Numbers in parenthesis indicate the concentration of acid.

*

2. Electrophiles
Electrophiles are important in chemistry.

The ability of these electron-

deficient/electron-seeking species to react with electron-rich/nucleus-seeking nucleophiles is
a fundamental concept in organic chemistry. Important to the chemistry presented in this
dissertation is the notion that the strength of carbon electrophiles (carbocations) is important
in driving chemical reactions.
Carbocations can be classified as primary, secondary, or tertiary based on the amount
of substitution at the cationic carbon (Figure 1.2). Primary carbocations are the least stable
and stability increases with functionalization. Added alkyl functionality to the carbocation
produces an inductive effect spreading the positive charge throughout the molecule.

4

Figure 1.2: Stability Trends of Substituted Carbocations
If the charge is localized, as it is in the case of a primary carbocation, the ion will be much
less stable. A methyl group for example will donate electron density to the carbocation.
Adding allylic or aryl groups to the carbocation also helps to stabilize the molecule through
resonance. As such, generating an unstable primary carbocation will be more difficult than a
tertiary carbocation. This is because the tertiary carbon is more energetically stable and will
therefore require much less energy to form than the primary or secondary carbocation.
In a 1972 paper published in the Journal of the American Chemical Society, George
Olah describes two distinct classes of carbocations: carbenium ions and carbonium ions.10
The “classical” carbenium ions can contain a planar sp 2-hybridized, electron deficient
carbenium center of which CH3+ is a parent. The “non-classical” carbonium ion can contain
either a penta- or tetra-coordinated, less electron deficient carbon atom bonded to four or five
ligands of which CH5+ is a parent (Figure 1.3).10

5

Figure 1.3: Examples of Carbonium Ions
Olah and co-workers were able to achieve this ion and describe it as involving three, twoelectron covalent bonds and a fourth two-electron, three center bond.10 Carbenium and
carbonium ions are the subject of many reviews and monographs. 10
Electrophile strength, or reactivity, can be quantitatively measured. Important kinetic
studies of carbocation-carbanion combinations were conducted by Mayr to quantify
electrophilicity and nucleophilicity.6,11

In Figure 1.4, the nucleophiles are ordered in

increasing reactivity from left to right and electrophiles are ordered in increasing reactivity
from top to bottom.11 The diagonal line identifies electrophile-nucleophile combinations that
proceed with a rate constant of 1 L mol-1 s-1 at 20oC.11 The region to the left of the diagonal
line in this graph represents electrophile-nucleophile combinations are too slow to take place

6

Figure 1.4: Model of Polar Organic Reactivity
at room temperature.11 Combinations to the right (hot zone) of the diagonal line are defined
as diffusion-controlled reactions and proceed with rate constants upwards of 10 10 L×mol-1×s-1

7

at 20oC.11 This model shows that arenes such as benzene and toluene are extremely weak
nucleophiles that only react with extremely strong electrophiles.
The model also shows that weak electrophiles require strong nucleophiles in order for
a reaction to be favored. One example of this is the Grignard reaction (Scheme 1.1). The
Grignard reagent, as described, has a strong nucleophilic carbon which can overcome the
weak electrophile and the reaction proceeds rapidy to give the thermodynamically stable
product (eq 1).

Scheme 1.1: General Grignard Reaction Mechanism
Chapter 2 and 4 of this dissertation deal with electrophilic aromatic substation (EAS)
reactions. In these types of reactions the aryl ring is susceptible to electrophilic attack
because of its exposed π-electrons.12 The benzene ring is considered an extremely weak
nucleophile. Therefore, it requires a strong electrophile for EAS reactions to occur. EAS
reactions such as nitration, bromonation, and sulfonation of benzene require formation of the
electrophile in the first step. This step is Lewis acid catalyzed for the bromination type of

8

EAS reactions. Halogenation of benzene with bromine will not take place unless a Lewis
acid is present in the mixture.12 Diatomic bromine is not electrophilic enough to attack the
weak nucleophile. By adding the Lewis acid and freeing the halogen cation, the reaction
takes place (Scheme 1.2). There are many other cases in which a strong acid is used to form
stronger electrophiles and drive an organic reaction. This dissertation describes research
focusing on the reactions weak nucleophiles with superelectrophiles in superacidic media.
Therefore, a discussion of superelectrophiles and their chemistry is useful.

Scheme 1.2: Mechanism for Bromination of Benzene Via Electrophilic Aromatic
Substitution
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3. Superelectophiles.
In superacid media, protonation of multiple weak base sites on a molecule is possible,
forming two or more cationic sites.

These multiply charged species, known as

superelecrophiles, have been shown to exhibit very high reactivity when compared to
monocations. One of the benefits of this high reactivity is the ability of superelectrophiles to
react with extremely weak nucleophiles.

Although some electrophiles can be isolated,

generally they are generated in situ with Brønsted or Lewis acids and react directly with the
nucleophile.6 Because of the opportunity to protonate multiple base sites on an organic
substrate, two or more equivalents of superacid are needed and superelectrophilic
conversions are often carried out in the presence of excess acid. Sulfuric acid has been used
in the generation of dications, however, it also has the ability to sulfonate or oxidize reactive
intermediates or substrates. Trifluoromethanesulfonic acid (triflic acid) is a stable, weakly
oxidizing acid and is the most wildly used catalyst and activating agent in superelectrophilic
chemistry.6 Figure 1.5 shows a variety of superelectrophiles of different categories. 13

Figure 1.5: Categories of Superelectrophiles
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Gitionic and distonic are two basic categories of superelectrophiles.

Gitionic or close

superelectrophiles are those where the charge centers are separated by no more than one
carbon or heteroatom.13 Distonic superelectrophiles are dications where the charge centers
are separated by two or more atoms.13
Evidence for superelectrophile activation comes in a variety of ways.

The best

evidence is direct observation. In some cases, stable dicationic intermediates such as 2 (eq 2,
Scheme 1.3) have been observed by low temperature

13

C-NMR.14

In equation (2) 2-

pyridinecarboxaldehyde 1 has been protonated at the nitirogen and carbonyl oxygen forming
superelectrophile 2 and the reaction gives 10% of product 3. The same reaction with
benzaldehyde 4, however shows no reaction even though monocation 5 is formed (eq 3).6
These direct observations are strong evidence for the support of superelectrophilic activation.
Gas-phase, mass spectral studies also are a means of direct observation of superelectrophiles
as noted by Olah.15
This is one of many such examples of superelectrophile chemistry where the reactive
superelectrophilic intermediate has been directly observed. The discussion that follows adds
to this growing body of work.

11

Scheme 1.3: Examples of Superelectrophic Chemistry
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CHAPTER 2

CYCLODEHYDRATION OF DIHYDROCINNAMOYL-FUNCTIONALIZED NHETEROCYCLES TO INDENES
1. Introduction
Functionalized indenes are useful scaffolds in synthetic and medicinal chemistry. 16
For example, indenes with N-heterocyclic substituents have been utilized as pharmaceutical
agents and metal ligands (Table 2.1).

Compound 3 (Fenistil™) is a well-known anti-

histamine drug.17 Traditionally, Fenistil™, generically named dimethpyrindene, is
synthesized in three steps (Eq. 1).

The first step is alkylation of 1-indanone with 2-

dimethylaminoethyl chloride to form 2-(dimethylaminoethyl)-indane-1-one 1 followed by
condensation with the lithium reagent obtained with 2-ethylpyridine affords the alcohol 2,
and, finally, dehydration of the alcohol by warming with weak aqueous acid gives Fenistil™
3.18

Scheme 2.1: Synthesis of Fenistil™

13
Recently, Korean scientists prepared N-heteropolycycles exhibiting spiroindanemotifs. These compounds have shown promising results in electroluminescent chemistry as
well as in catalyst design. For example, the electroluminescent material 4 exhibits a 31.05
candela/m2 and can be obtained in three steps over five stages. 19 Padgett and Huffman
developed a series of pyrroles and indenes, some of which were found to be potent
cannabinoids and subsequently employed as rigid models for the receptor interactions of
cannabimimetic indoles with the cannabinoid brain receptor (CB(1)). 20 The synthetic
cannabinoid naphthylethylindene 5 was found to have an affinity for CB1 and cannabinoid
type 2 receptors similar to that of tetrahydrocannabinol (Δ9-THC).

Table 2.1: Indene and Spirocycle Examples
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Pyridyl-substituted indenes have also been used to prepare zirconium complex 6,21
manganese complex 7,22 and ruthenium complexes.23 The reactivity and catalytic activity of
monometallic transition metal complexes of the indenyl ligand are significantly greater than
those of analogous mononuclear complexes (i.e. ligands coordinated to one metal nucleus).
In the case of the reaction Rh(ɳ5-C9H7)(CO)2 with PPh3 the substitution occurs 3.8 x 108
times faster than the analogous cyclopentadienyl compound. 24 This phenomenon known as
the “indenyl effect”, a term coined by Professor Fred Basolo, extends itself to fluorene and
naphthalene systems as well.25 Homo-, heterobimetallic, and even trimetallic organometallic
complexes are also of great interest for both stoichiometric and catalytic reactions. 7 Complex
8 contains a pyridyl indenyl ligand which behaves as a tridentate cyclometalated ligand. The
ligand of this trinuclear ruthenium complex 8 is involved in an unprecedented µ3-ɳ6:ɳ3:ɳ1coordination mode.7 Bimetallic and trimetallic complexes are interesting in that cooperative
interaction between the two metal centers may cause increased reaction rates either through
strong through-bond interaction facilitated by the bridging ligand or from direct metal-metal
interaction.8 In summary, heterocyclic indenes can play an important role in many facets of
chemistry including medicinal organic chemistry, electrochemistry, and organometallic
catalysis.
A number of reactions for the formation of the indene functional group are known.
However, common methods often require the use of expensive transition metal catalysts,
complex reaction setups, or long reaction time. 26,27,28 Work has been done by Lautens
regarding the utility of trisubstituted allylic alcohols as synthons for indenes and quinolines.29
These rhuthenium catalyzed reactions require 15-50 hours at 80 oC. Lautens also reports a
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tandem, palladium-catalyzed intermolecular Suzuki/intramolecular Heck reaction for the
formation of indenes.30

Most recently, Phil Ho Lee reported Brønsted acid catalyzed

cyclization of diaryl and alkyl-1,3-dienes to indenes.31 Despite the previous work, there was
still the need for a synthetic method giving functionalized indenes.
Cyclodehydration is a well-known route to carbocyclic products. 32 Many polycyclic
aromatic hydrocarbons have been prepared using this chemistry. 33 Product ring systems
include dihydronaphthalenes and indenes.

The conversions involve the acid-promoted

reactions of aldehydes, ketones, or analogous substrates and they often occur through
carboxonium ion intermediates. Over the years, the Klumpp group has described several
types of superelectrophilic condensation reactions involving dicationic carboxonium ions. 6,3437

These types of reactive intermediates have shown high reactivities in Friedel-Crafts-type

reactions.

This chapter describes a cyclodehydration to give indenes with heterocyclic

substituents and a mechanism is proposed involving dicationic carboxonium ions as the key
intermediate.
2. Results and Discussion
To begin our studies, we sought to prepare dihydrocinnamoyl-substituted
heterocycles. Two approaches to these starting materials were found to be useful. The first
involves the reaction of a heterocyclic nitrile with phenethylmagnesium bromide to give an
intermediate imine that is hydrolyzed with dilute HCl (eq 2). The second method involves
the formation of the heterocyclic organolithium reagent (eq 3).
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Scheme 2.2: Synthetic Routes to Dihydrocinnamoyl-Substituted Heterocycles
The organolithium reagent reacts with hydrocinnamaldehyde to give an alcohol. The
crude alcohol is then subjected to known Swern oxidation conditions to afford the
dihydrocinnamoyl-substituted heterocycle. A series of dihydrocinnamoyl-substituted
heterocycles 9-16 were prepared and reacted with triflic acid, CF3SO3H, to give the
cyclodehydration products (Table 2.1).

In general, the expected indene products were

formed in good yields. Some indenes were found to be somewhat unstable unless stored at a
low temperature under an inert atmosphere. The product indenes include pyridyl, pyrimidyl,
imidazolyl, oxazolyl, thiazolyl, and benzothiazolyl derivatives 17-24. Cyclization of ketone
16 leads to 24, an analog of fenistil 3, rather than a product having an exocyclic double bond.
Good conversion of 9 to 17 was also accomplished using perfluoro(2-ethoxyethane)sulfonic
acid, another Brønsted superacid.

Other acids (such as concentrated sulfuric acid,

trifluoroacetic acid, BF3 •OEt2, and TiCl4) did not promote the conversion of 9 to 17 in
reactions at 25°C. As few as 4 equivalents of CF3 SO3H promoted the cyclization of 9 to 17,
but the synthesis proceeds to 100% conversion within 4 hours when 12 or more equivalents
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of acid are used.

The CF3SO3H may be quantitatively recycled using a published

procedure.38
When the ketone substrates have pendant aryl groups, they may undergo a second
cyclization, leading to spirocyclic indanes (eqs 4-5). Thus, the imidazole and quinolone
derivatives (25 and 27) provide the respective spirocyclic products (26 and 28) in excellent
yields.
In these dehydrative cyclizations, a mechanism is proposed involving a series of
dicationic intermediates (Scheme 1). Protonation of the pyridyl nitrogen and the carbonyl
group leads to the superelectrophilic carboxonium ion intermediate 29. Cyclization of the
carboxonium ion 29 provides the dicationic oxonium ion 30 and dehydration gives the
carbocation 31. Deprotonation steps then give the observed indene product 17.
In the case of the spirocyclic product 26, the indenyl intermediate 32 is likely in
equilibrium with the superelectrophilic carbocation 33, as small amounts of the
corresponding indene product, 26B, may be isolated if the reaction is done at low
temperature (eq 6). Thus, the superelectrophile 33 undergoes cyclization with the phenyl
group to give product 26. A similar process is envisaged for spirocyclic product 28.

18

Table 2.2: Cyclodehydration Substrates, Products, and Yields

19

Scheme 2.3: Cyclodehydration Reactions to Spirocyclic N-heterocycles

Scheme 2.4: Proposed Mechanisms of Dehydrative Cyclizations
In the case of the spirocyclic product 26, the indenyl intermediate 32 is likely in
equilibrium with the superelectrophilic carbocation 33, as small amounts of the
corresponding indene product, 26B, may be isolated if the reaction is done at low
temperature (eq 6). Thus, the superelectrophile 33 undergoes cyclization with the phenyl
group to give product 26. A similar process is envisaged for spirocyclic product 28.

20

Scheme 2.5: Proposed Mechanism for Secondary Cyclization to Spirocycles
However, when ketone 13 is treated with triflic acid, even at elevated temperatures,
only indene 21 is formed, not spirocycle 34 (Scheme 2.6, A).

Increased bond angles

between substituents on the 5-membered ring may be preventing the nucleophilic phenyl
group and the superelectrophilic carbocation from interacting. This type of cyclization can
be classified in terms of Baldwin’s rules as a 5-exo-trig ring closure. For this type of
cyclization to be favored, a ~105o-109o degree angle is required for nucleophilic attack at the
sp2 carbon.39 Instead, deprotonation steps complete the cyclodehydration to 21, as in the
proposed general (Scheme 2.6, B)

21

Scheme 2.6: Clarification of Reaction Mechanism for Subtrate 13
In three other cases the reaction was unsuccessful. The synthesis of starting materials
35, 36, and 37. Equation 7 illustrates the reaction of 5-hydrocinnamoyl pyrimidine with
triflic acid in dichloromethane. This conversion was unsuccessful at various temperatures.
Crude GC-MS shows a single peak with a m/z of M-2 and TLC shows a single spot.
However, after isolation of this spot NMR analysis could not confirm the structure. The peak
may be the result of decomposition of a polymeric product. The reaction of 36 in triflic acid
yielded only starting material over a range of temperatures (eq 8). Although it would seem
that the three electron-donating methoxy groups would activate the ring, making it a stronger
nucleophile, the reaction was unsuccessful. Either the functionalization in close proximity to
the nucleophilic carbon hinders the attack at the carbonyl carbon or, more likely, the ring is
protonated and no reaction takes place. Finally, the aryl nucleophilic group was replaced by
ferrocene (eq 9) as a possible analog of the known organometallic catalysts mentioned above.
Unfortunately, this reaction also only produced starting material 37. This substrate was also
tried at various temperatures with only starting material recovered.
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Table 2.3: Failed Cyclodehydration Reactions
In order to evaluate the effects of the pyridinium ring on the cyclodehydration, the
cyclization of compound 9 was compared with the same reaction involving 1,3diphenylpropan-1-one 38.11 Previous work by Shudo and Ohwada estimated the pKBH+
value for compound 38 to be -5.9 in CF3SO3H-CF3CH2OH solution.40 Cyclodehydration of
38 may be accomplished in good yield with CF3SO3H (Ho -14), but it requires elevated
temperature (eq 10).

NMR experiments indicated that compound 38 is completely

protonated in solutions more acidic than Ho -9 and evidence from kinetic experiments have
suggested the involvement of superelectrophile 41 as the key reactive intermediate in the
cyclodehydration (eq 11).34 If the monocationic species 40 undergoes cyclization to the
indene, it does so at an exceedingly slow rate.40
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Scheme 2.7: Cyclodehydration of 1,3-diphenylpropan-1-one (38)
Both compounds 9 and 38 were separately mixed with excess CF3SO3H and the
relative rates of cyclization were compared (Figure 1). The conversions were done by
combining a solution of the ketone in CH2Cl2 with CF3SO3H and the mixture was quenched
after the reaction period. The product mixtures were then subjected to GC-FID analysis.
The heterocyclic ketone 9 was completely converted to the indene condensation product 17
within 30 minutes. Conversely, no detectable condensation product 39 was observed during
the same reaction period from 1,3-diphenylpropan-1-one 38. This is consistent with Shudo
and Ohwada’s observation that forcing conditions are required for cyclodehydration of
compound 38 in CF3SO3H. At 25°C, the reaction of 38 with CF3SO3H presumably involves
formation of the monocation carboxonium ion intermediate 40 with little or no
superelectrophile 39 formation. Thus, indene 31 is not produced.
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x = Conversion to 39
o = conversion to 17

Figure 2.1: Cyclodehydrations (9 to 17 and 38 to 39) in TfOH at 25°C.
The facile cyclodehydration of compound 9 may be understood with the involvement
of the dicationic intermediate 29.

Previous work has shown the activating effects of

protonated N-heterocyclic rings on adjacent electrophilic sites. 41-44

In this case, the

pyridinium ring of 29 enhances the reactivity of the neighboring carboxonium ion group.
Several protonated heterocyclic ketones were studied computationally and compared with the
monocationic intermediates 40 and 42 (Figure 2). All calculations were done using the
program suite Gaussian09 by Professor Klumpp at the B3LYP 6-311G(d,p) level.45 In all
cases, the dicationic species exhibit significantly lowered LUMO orbitals compared to the
monocationic species, and not surprisingly, the LUMO coefficients are high at the
carboxonium carbon (see LUMO 29). Moreover, the heterocyclic dications (29, 43-45) all
exhibit LUMO energy levels (-11.51 to -12.08 eV) comparable to that of the
superelectrophilic carboxonium dication 41 (-11.81 eV). Olah and Koltunov have previously
correlated the relative reactivities of superelectrophiles with LUMO characteristics.46 These
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observations are consistent with the electrophilic activating effects of protonated Nheterocyclic rings. It also is notable that the heterocyclic dications (29, 43-45) are formed by
protonation of a strong base site – the heterocyclic ring – and a relatively weak base site – the
carbonyl group. With the superelectrophilic carboxonium dication 41, superelectrophile
formation requires protonation of two weak base site – the carbonyl group and carboxonium
oxygen.
3. Conclusions
In summary, we have described a convenient route to N-heterocyclic substituted
indenes.

The chemistry involves a cyclodehydration of 3-phenyl-1-propanones in

superacidic solution. The results suggest a significant role of the protonated N-heterocycle in
activation of the electrophilic carboxonium ion. Previously, aryl-substituted indenes have
been synthesized from the dehydration of functionalized indanols (which were prepared from
the corresponding 1-indanones and an organometallic reagent). 47-49 The present work
involving superelectrophilic cyclizations is general in scope and it improves synthetic access
to functionalized indenes – a structure with general utility.
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4. Experimental Section
General.
atmosphere.

All reactions were performed using oven-dried glassware under an argon
Trifluoromethanesulfonic acid was freshly distilled prior to use.

commercially available compounds and solvents were used as received.

1

H NMR and

All
13

C

NMR were done using a 300 MHz spectrometer; chemical shifts were made in reference to
NMR solvent signals.

Low-resolution mass spectra were obtained from a gas

chromatography instrument equipped with a mass-selective detector, while high-resolution
mass spectra were obtained from a commercial analytical laboratory (electron impact
ionization; sector instrument analyzer type). Triflic acid may also be recovered and recycled
quantitatively.16
Preparation of 1,3-diarylpropan-1-one Derivatives, General Method A:
The heterocyclic nitrile (2 mmol) is dissolved in anhydrous ether (20 mL) and cooled
to 0 °C. To this solution, phenethylmagnesium chloride (2.4 mL, 1.0 M in THF) is slowly
added, stirred for 2 h at 0°C and warmed to 25°C, and then it is quenched with ca. 3 mL of
1.0 M HCl. This solution is stirred overnight. Following neutralization with 2 M NaOH, the
product mixture is partitioned between ether and water. The aqueous phase is subjected to
two further extractions with ether and the combined ether extracts are washed with water and
then brine. After drying the solution with anhydrous Na2SO4, the solvent is evaporated. The
product 1,3-diarylpropan-1-one may be purified by column chromatography (silica gel,
ether:hexane or ethyl acetate:hexane).
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Preparation of 1,3-diarylpropan-1-one Derivatives, General Method B:
The heterocyclic substrate (2 mmol) is dissolved in anhydrous THF (15 mL), the
solution is cooled to -78 °C, and n-BuLi solution (5.25 mL, 2.5 M in THF, 2.1 mmol) is
added slowly with stirring. Following a two-hour period, hydrocinnamaldehyde (2 mmol in
5 mL of THF) is added and the solution is allowed to warm to room temperature. Stirring for
two hours is followed by a work-up procedure: water (20 mL) is added to the mixture, the
organic phase is partitioned off, and the aqueous phase is extracted twice ether.

The

combined organic extracts are washed twice with brine and then dried with anhydrous
sodium sulfate. The crude alcohol is then isolated by removal of solvent with reduced
pressure.

The crude alcohol is oxidized to the corresponding ketone using an adapted

procedure from the literature.50,51
Cyclodehydration to the HeterocyclicIndenes, General Method C:
The heterocyclic ketone (1 mmol) is dissolved in CH2Cl2 (2 mL) and CF3SO3H is
added to the stirred solution. After 4 h, the mixture is poured over ca. 10 g of ice and 50 mL
CHCl3. The aqueous layer is then made basic (ca. pH 8) by addition of 10 M NaOH and the
mixture partitioned in a separatory funnel. The aqueous layer is extract twice with CHCl 3,
the combined organic extracts are washed with water then brine, and the solution is dried
over anhydrous sodium sulfate. Although the indene products are often obtained in greater
than 95% purity, the products may be further purified with silica gel chromatography.
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1-(3-Methylpyridin-2-yl)-3-phenylpropan-2-one (10).

Using general method A,

compound 10 is isolated as a clear, yellow oil in 87% yield, R f=0.30 (4:1 hexane:ether). 1H
NMR (CDCl3, 300 MHz) δ 2.57 (s, 3H), 3.07 (t, J=7.4 Hz, 2H), 3.58 (t, J=8.0 Hz, 2H), 7.177.35 (m, 6H), 7.55(dq, J=0.7, 1.6, 7.7 Hz, 1H), 8.50 (dd, J=1.2, 4.6 Hz, 1H).

13

C NMR

(CDCl3, 75 MHz) δ 20.2, 30.1, 41.4, 125.9, 126.0, 128.4, 128.5, 134.4, 140.1, 141.5, 146.1,
151.8, 203.2. Low resolution mass spectrum (EI): 225 (M+), 197, 182, 93, 65. Highresolution mass spectrum (EI), calcd for C15H15NO, 225.1154, found 225.1157.

1-(1-Benzyl-1H-imidazol-2-yl)-3-phenylpropane-1-one (25).

Using general method B,

compound 25 is isolated as clear, yellow oil in 68%, Rf=0.12 (5:1 hexane:ethyl acetate). 1H
NMR (CDCl3, 500 MHz) δ 3.07 (t, J=7.7 Hz, 2H), 3.54 (t, J=8.0 Hz, 2H), 5.65 (s, 2H), 7.10
(d, J=0.8 Hz, 1H), 7.19-7.23 (m, 4 H), 7.28-7.39 (m, 7H).

13

C NMR (CDCl3, 125 MHz) δ

30.0, 40.7, 51.8, 126.1, 127.6, 128.1, 128.4, 128.5, 128.9, 129.5, 136.4, 141.0, 142.4, 192.1.
Low resolution mass spectrum (EI): 290 (M+), 262, 185, 157, 91. High-resolution mass
spectrum (EI), calcd for C19H18N2O, 290.1419, found 290.1419.
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3-Phenyl-1-(pyridin-2-yl)propan-1-one (9).

Using general method A, compound 9 is

isolated as a clear, light yellow oil in 88% yield, Rf=0.27 (4:1 hexane:ether).

1

H NMR

(CDCl3, 300 MHz) δ 3.09 (t, J=7.9 Hz, 2H), 3.60 (t, J=7.95 Hz, 2H), 7.17-7.24 (m, 1H),
7.27-7.34 (m, 4H), 7.48 (dq, J=7.6, 4.8, 1.2 Hz, 1H), 7.84 (dt, J=7.7, 1.7 Hz, 1H), 8.1 (dt,
J=7.9, 1.1 Hz, 1H), 8.68 (dq, J=4.7, 1.7. 0.9 Hz, 1H).

13

C NMR (CDCl3, 75 MHz) δ 29.9,

39.4, 121.8, 126.0, 127.1, 128.4, 128.5, 136.9, 141.4, 148.9, 153.3, 201.0. Low resolution
mass spectrum (EI): 211 (M+), 183, 182, 107, 91, 79. High-resolution mass spectrum (EI),
calcd for C14H13NO, 211.0997, found 211.0996.

3-Phenyl-1-(pyrimidin-2-yl)propan-1-one (11). Using general method A, compound 11 is
isolated as clear, yellow oil in 80% yield, Rf=0.6 (100% ether).

1

H NMR (CDCl3, 300 MHz)

δ 3.13 (t, J=7.2 Hz, 2H), 3.60 (t, J=8.1 Hz, 2H), 7.13-7.31 (m, 6H), 7.46 (t, J=4.8 Hz, 1H),
8.93 (d, J=4.9, 1H).

13

C NMR (CDCl3, 75 MHz) δ 29.8, 40.8, 124.0, 136.1, 128.5, 128.5,

141.1, 157.6, 160.0, 198.9. Low resolution mass spectrum (EI): 212 (M+), 183, 169, 105,
80. High-resolution mass spectrum (EI), calcd for C13H12N2O, 212.0950, found 212.0952.
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1-(1-Butyl-1H-imidazol-2-yl)-3-phenylpropan-1-one (12). Using general method B, 1butylimidazole (0.5 mL, 3.83 mmol) gives compound 12 which is isolated (0.673g, 2.63
mmol, 69%) as a clear, light brown oil, Rf=0.11 (5:1 hexane:ether).

1

H NMR (CDCl3, 500

MHz) δ 0.92 (t, J=7.4 Hz, 3H), 1.26-1.34 (m, 2H), 1.67-1.73 (m, 2H), 3.04 (t, J=7.5 Hz, 2H),
3.48 (t, J=8.0 Hz, 2H), 4.34 (t, J=7.4 Hz, 2H), 7.01 (d, J=0.8 Hz,1H), 7.10 (d, J=0.9 Hz, 1H),
7.12-7.17 (m, 1H), 7.24 (s, 2H), 7.25 (s, 2H).

13

C NMR (CDCl3, 75 MHz) δ 13.6, 19.7, 30.0,

33.1, 40.7, 48.4, 125.9, 125.9, 128.3, 128.4, 129.0, 141.1, 142.3, 191.7. Low resolution mass
spectrum (EI): 256 (M+), 228, 199, 123, 82. High-resolution mass spectrum (EI), calcd for
C16H20N2O, 256.1576, found 256.1569.

1-(2,5-Diphenyloxazol-4-yl)-3-phenylpropan-1-one (13).

Using general method B,

compound 13 is isolated as colorless solid resin (mp 107-109 °C) in 31% yield, Rf=0.18 (5:1
hexane:ether). 1H NMR (CDCl3, 300 MHz) δ 3.13 (t, J=7.4 Hz, 2 H), 3.55 (t, J=8.2 Hz, 2H),
7.22-7.29 (m, 1H), 7.34 (s, 2H), 7.36 (s, 2H), 7.50-7.57 (m, 6H), 8.13-8.19 (m, 2H), 8.298.33 (m, 2H).

13

C NMR (CDCl3, 75 MHz) δ 30.0, 42.7, 126.0, 126.7, 127.3, 128.1, 128.5,

128.5, 128.6, 128.9, 130.6, 131.0, 135.1, 141.5, 153.2, 158.7, 195.9. Low resolution mass
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spectrum (EI): 353 (M+), 325, 251, 221, 105. High-resolution mass spectrum (EI), calcd for
C23H19N3O, 353.1528, found 353.1414.

3-phenyl-1-(thiazol-2-yl)propan-1-one (14). Using general method B, compound 14 is
isolated as clear, colorless oil in 48% yield, Rf=0.44 (5:1 hexane:ethyl acetate).

1

H NMR

(CDCl3, 300 MHz) δ 3.13 (t, J=7.6 Hz, 2H), 3.54 (t, J=7.9 Hz, 2H), 7.21-7.24 (m, 1H), 7.297.34 (m, 4H), 7.66 (d, J=3.1 Hz, 1H), 8.01 (d, J=3.1 Hz, 1H).

13

C NMR (CDCl3, 75 MHz) δ

30.0, 40.1, 126.2, 126.3, 128.49, 128.52, 140.8, 144.8, 167.0, 193.0. Low resolution mass
spectrum (EI): 217 (M+), 189, 188, 112, 85. High-resolution mass spectrum (EI), calcd for
C12H11NOS, 217.0561, found 217.0562.

1-(benzo[d]thiazol-2-yl)-3-phenylpropan-1-one (15). Using general method B, compound
15 is isolated as a light yellow solid (mp 69-70 °C) in 59% yield, Rf=0.47 (5:1 hexane:ether).
1

H NMR (CDCl3, 500 MHz) δ 3.17, (t, J=7.5 Hz, 2H), 3.67 (t, J=8.0 Hz, 2H), 7.23-7.26 (m,

1H), 7.33-7.35 (m, 4H), 7.54-7.62 (m, 2 H), 8.00-8.01 (m, 1H), 8.19-8.21 (m, 1H).

13

C NMR

(CDCl3, 125 MHz) δ 29.7, 40.4, 122.5, 125.4, 126.3, 127.0, 127.8, 128.6, 137.2, 140.7,
153.5, 166.2, 194.5. Low resolution mass spectrum (EI): 267 (M+), 238, 162, 135, 91.
High-resolution mass spectrum (EI), calcd for C16H13NOS, 267.0718, found 267.0717.
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1-Phenyl-4-(pyridin-2-yl)pentan-3-one (16).

2-Ethylpyridine (0.286 mL, 2.5 mmol) is

dissolved in 15 mL THF and the solution cooled to -5 °C. n-BuLi (1.0 mL, 2.5 M solution in
hexanes, 2.5 mmol) was added and this solution is stirred for 45 min. To this solution, 0.328
mL hydrocinnamonitrile (2.5 mmol, 0.328g) is added and the mixture is allowed to stir for 30
minutes. Following this period, 2 M HCl (30 mL) is added and the solution stirred for 10
min. The solution is made basic with 10% NaOH solution and extracted three times with
CHCl3. The organic extracts are combined, washed with H2O and then brine, dried over
sodium sulfate, and the solvent is evaporated. Compound 16 is isolated as a clear, yellow oil
(0.1089g, 0.46 mmol, 18%), Rf=0.20 (4:1 hexane:ethyl acetate).

1

H NMR (CDCl3, 300

MHz) δ 1.46 (d, J=7.0 Hz, 3H), 2.72-2.80 (m, 2H), 2.84-2.92 (m, 2H), 4.00 (q, J=7.0, 1H),
7.08-7.25 (m, 7H), 7.60-7.65 (td, J=7.7 Hz, 1.9 Hz, 1H), 8.54-8.56 (m, 1H).

13

C NMR

(CDCl3, 75 MHz) δ 16.2, 29.8, 42.9, 55.3, 122.1, 122.3, 126.0 128.3, 128.4, 137.0, 141.0,
139.5 160.0. Low resolution mass spectrum (EI): 239 (M+), 224, 107, 106, 91. Highresolution mass spectrum (EI), calcd for C16H17NO, 239.1310, found 239.1311.

2-(1H-inden-3-yl)-3-methylpyridine (18). Using general method C, ketone 10 (0.2251g,
1.0 mmol) provides compound 18 0.1749g, 0.85 mmol (87%) as a clear, orange oil. R f=0.21
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(7:1 hexane:ethyl acetate).

1

H NMR (CDCl3, 500 MHz) δ 2.37 (s, 3H), 3.61 (d, J=1.8 Hz,

2H) 6.68 (t, J=1.8 Hz, 1H), 7.20-7.39 (m, 4H), 7.54-7.57 (m, 1H), 7.61-7.66 (m, 1H), 8.59 (d,
J=3.9 Hz, 1H).

13

C NMR (CDCl3, 125 MHz) δ 19.6, 38.6, 121.1, 122.2, 123.8, 124.9, 126.2,

132.0, 133.4, 138.2, 143.8, 143.8, 144.3, 146.9, 154.4. Low resolution mass spectrum (EI):
207 (M+), 206, 180, 102.

High-resolution mass spectrum (EI), calcd for C15H13N,

207.10480, found 207.10441.

2-(1H-indene-3-yl)pyrimidine (19). Using general method C, ketone 11 (0.1051g, 0.496
mmol) provides compound 19 (0.0662, 0.341 mmol, 69%) as a clear, dark red resin; R f=0.21
(9:1 hexane:ethyl acetate). 1H NMR (CDCl3, 300 MHz) δ 3.63 (d, J=2.1 Hz, 2H), 7.19-7.22
(m,1H), 7.28-7.34 (m, 2H), 7.40-7.57 (m, 2H), 7.68 (t, J=2.1 Hz, 1H) 8.57 (d, J=7.7 Hz, 1H),
8.85 (d, J=4.8 Hz, 1H).

13

C NMR (CDCl3, 75 MHz) δ 38.3, 119.0, 123.3, 123.8, 125.1,

123.4, 128.5, 139.4, 142.9, 144.9, 156.9, 163.1. Low resolution mass spectrum (EI): 194
(M+), 193, 168, 140, 115.

High-resolution mass spectrum (EI), calcd for C13H10N2,

194.08440, found 194.08441.

1-butyl-2-(1H-inden-3-yl)-1H-imidazole (20).

Using general method C, ketone 12

(0.1209g, 0.472 mmol) provides compound 20 (0.11g, 0.462 mmol, 98%) as a brown oil.
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1

Rf=0.22 (1:1 hexane:ethyl acetate).

H NMR (CDCl3, 500 MHz) 0.78 (t, J=7.5 Hz, 3H),

1.13-1.23 (m, 2H) 1.69-1.75 (m, 2H), 3.66 (s, 2H), 4.12 (t, J=7.5 Hz, 2H), 7.19 (s, 1H). 7.227.32 (m, 3H), 7.40 (s, 1H), 7.52-7.53 (m, 2H).

13

C NMR (CDCl3, 125 MHz) δ 13.3, 19.3,

32.3, 39.8, 48.4, 120.1, 120.7, 121.9, 124.6, 126.7, 127.0, 127.3, 140.0, 140.3, 143.1, 143.4.
Low resolution mass spectrum (EI): 238 (M+), 223, 209, 182, 127. High-resolution mass
spectrum (EI), calcd for C16H18N2, 238.14700, found 238.14720.

4-(1H-inden-3-yl)-2,5-diphenyloxazole (21). Using general method C, ketone 13 (0.1195g,
0.339 mmol) provides compound 21 (0.0798g, 0.238 mmol, 70%) as a clear, light brown oil.
Rf=0.65 (9:1 hexane:ethyl acetate).

1

H NMR (CDCl3, 300 MHz) δ 3.63 (d, J=2.1 Hz, 2H),

6.93 (t, J=1.8 Hz, 1H), 7.25-7.57 (m, 10H), 7.71-7.74 (m, 2H), 8.20-8.23 (m, 2H).

13

C NMR

(CDCl3, 75 MHz) δ 38.77, 121.62, 123.76, 125.08, 126.19, 126.50, 127.38, 128.29, 128.58,
128.71, 128.79, 130.40, 131.90, 134.34, 136.52, 143.18, 143.98, 146.81, 160.13.

Low

resolution mass spectrum (EI): 335 (M+), 306, 231, 2-3, 202, 77. High-resolution mass
spectrum (EI), calcd for C24H17N, 335.13102, found 335.13051.
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2-(1H-inden-3-yl)thiazole (22). Using general method C, ketone 14 (0.1088g, 0.5mmol)
provides compound 22 (0.0856g, 0.043 mmol, 86%) as a white solid (mp 96-102 °C).
Rf=0.40 (9:1 hexane:e thyl acetate). 1H NMR (CDCl3, 300 MHz) δ 3.61 (d, J=2.3, 2H), 7.17
(t, J=2.3 Hz, 1H), 7.28-7.36 (m, 2H), 7.44 (t, J=8.0 Hz, 1H), 7.55 (d, J=7.4 Hz, 1H), 7.96 (d,
J=3.3 Hz, 1H), 8.33 (d, J=7.7 Hz, 1H).

13

C NMR (CDCl3, 75 MHz) δ 38.5, 118.2, 122.2,

123.9, 125.7, 126.6, 135.1, 138.0, 141.6, 143.2, 144.0, 163.3. Low resolution mass spectrum
(EI): 199 (M+), 154, 140, 115, 58. High-resolution mass spectrum (EI), calcd for C12H9NS,
199.04557, found 199.04520.

2-(1H-inden-3-yl)benzo[d]thiazole (23). Using general method C, ketone 15 (0.1321g,
0.514 mmol) provides compound 23 (0.0982g, 0.394 mmol, 77%) as a light grey solid (mp
100-102 °C). Rf=0.34 (9:1, hexane:ether). 1H NMR (CDCl3, 500 MHz) δ 3.66 (d, J=2.2 Hz,
2H), 7.30 (t, J=2.3 Hz, 1H), 7.37 (td, J=1.1, 7.5 Hz, 1H), 7.4 (td, J=1.1, 7.5 Hz, 1H), 7.49 (t,
J=7.3 Hz, 1H), 7.53-7.58 (m, 2H), 7.94 (d, J=8.0 Hz, 1H), 8.18 (d, J=8.1 Hz, 1H), 8.57 (d,
J=7.7 Hz, 1H).

13

C NMR (CDCl3, 75 MHz) δ 35.8, 121.4, 122.8, 123.6, 123.9, 125.4, 125.9,

126.2, 126.7, 134.4, 137.9, 138.6, 141.5, 143.9, 154.0, 163.0. Low resolution mass spectrum
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(EI): 249 (M+), 217, 140, 115. High-resolution mass spectrum (EI), calcd for C16H11NS,
249.06122, found 249.06088.

2-(1-(1H-inden-3-yl)ethyl)pyridine (24). Using general method C, ketone 16 (0.1070g,
0.45 mmol) provides compound 24 (0.0917g, 0.415 mmol, 92%) as a yellow oil. Rf=0.24
(9:1, hexane:ethyl acetate).

1

H NMR (CDCl3, 300 MHz) δ 1.73 (d, J=7.2 Hz, 3H), 3.44 (s,

2H), 4.33 (tdd, J=7.1 Hz, 1.7 Hz, 1H), 6.46 (d, J=1.7 Hz, 1H), 7.11 (ddd, J=7.45 Hz, 4.90
Hz, 1.10 Hz, 1H), 7.16-720 (m, 4H), 7.45-7.49 (m, 1H), 7.55 (td, J=15.37 Hz, 1H), 8.60-8.63
(m, 1H).

13

C-NMR (CDCl3, 75 MHz) δ 20.1, 37.8, 41.6, 120.1, 121.4, 121.7, 123.7, 124.6,

125.9, 128.6, 136.6, 144.6, 144.7, 147.2, 149.2, 164.4). Low resolution mass spectrum (EI):
221 (M+), 220, 206, 204, 115. High-resolution mass spectrum (EI), calcd for C19H16N2,
222.1283, found 222.1286.

2’,3’-Dihydro-5H-spiro[imidazo[1,2-b]isoquinoline-10,1’-indene] (26).

Using general

method C, ketone 25 (0.1256g, 0.433 mmol) provides compound 26 (0.1171g, 0.431 mmol,
98%) as a transparent, yellow oil. Rf= 0.27 (1:1, hexane:ether). 1H NMR (CDCl3, 500 MHz)
δ 2.54-2.59 (m, 1H), 2.76-2.81 (m, 1H), 3.19-3.25 (m, 1H), 3.43-3.49 (m, 1H), 5.52 (d,
J=17.0 Hz, 1H), 5.67 (d, J=17 Hz, 1H), 6.82, (d, J=7.7 Hz, 1H), 6.82 (dd, J=0.8, 7.7 Hz, 1H),
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7.18-7.21 (m, 1H), 7.28-7.44 (m, 6H), 7.62 (s, 1H).

13

C NMR (CDCl3, 125 MHz) δ 30.8,

43.0, 48.2, 52.4, 120.2, 120.7, 142.7, 125.9, 126.3, 126.9, 127.1, 128.1, 128.2, 129.3, 129.5,
136.8, 142.4, 144.4, 148.4. Low resolution mass spectrum (EI): 272 (M+), 271, 257, 230,
202, 128.

High-resolution mass spectrum (EI), calcd for C19H16N2, 272.13135, found

272.13185.

3-Phenyl-1-(2-phenylquinolin-3-yl)propan-1-one (27). 2-Phenylquinoline-3-carbaldehyde
(0.117g, 0.50 mmol) is dissolved in 15 mL of anhydrous ether and the solution is cooled to 0
°C.

To this solution, phenethylmagnesium chloride (0.6 mL, 1.0 M in THF, 0.6 mmol) is

added and the mixture is stirred at room temperature for 4 hrs. The reaction mixture is then
quenched with slightly acidic water (20 mL H2O with several drops of 1.0 M HCl) and 40
mL of ether is added. The products are extracted into the ether. The resulting organic
solution is washed with brine and dried with anhydrous sodium sulfate. The crude alcohol is
oxidation to provide the crude ketone.17 Ketone 27 is isolated (0.114 g, 0.34 mmol, 68%) as a
colorless oil. Rf=0.51 (5:1 hexane:ether).

1

H NMR (CDCl3, 500 MHz) δ 2.73 (t, J=7.3 Hz,

2H), 2.85 (t, J=7.8 Hz, 2H), 6.96 (d, J=7.1 Hz, 2H), 7.14-7.29 (m, 3H), 7.53, (d, J=1.4 Hz,
1H), 7.54 (d, J=1.8 Hz, 2H), 7.63-7.66 (m, 1H), 7.69-7.71 (m, 2H), 7.85-7.88 (m, 1H), 7.93
(d, J=7.7 Hz, 1H), 8.30 (s, 1H), 8.34 (d, J=7.9, 1H).

13

C NMR (CDCl3, 125 MHz) δ 30.7,

44.6, 126.1, 126.2, 127.6, 128.3, 128.4, 128.42, 128.96, 129.0, 129.3, 129.7, 131.7, 134.8,
137.4, 140.3, 147.5, 156.3, 204.8. Low resolution mass spectrum (EI): 337 (M+), 246, 232,
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204, 176.

High-resolution mass spectrum (EI), calcd for C24H19NO, 337.1466, found

337.1467.

2,3-Dihydrospiro[indene-1,11’-indeno[1,2-b]quinoline (28).

Using general method C,

ketone 27 (0.0233g, 0.069 mmol) provides compound 28 (0.0209g, 0.066 mmol, 95%) as an
oil. Rf=0.38 (4:1, hexane:ether).

1

H NMR (CDCl3, 300 MHz) δ 2.66-2.77 (m, 2H), 3.42-

3.51 (m, 2H), 6.53 (d, J=7.6 Hz, 1H) 7.02-7.06 (m, 1H), 7.25-7.33 (m, 2H), 7.43-7.55 (m,
4H), 7.68-7.74 (m, 2H), 7.89 (s, 1H), 8.27 (dd, J=8.3, 25.1 Hz, 2H).

13

C NMR (CDCl3, 75

MHz) δ 32.0, 40.7, 60.7, 121.8, 123.7, 124.1, 125.0, 125.8, 127.2, 127.5, 127.9, 128.0, 128.1,
129.0, 129.1, 130.1, 131.0, 138.7, 144.2, 144.6 147.5, 148.5, 154.2, 160.5. Low-resolution
mass spectrum (EI): 319 (M+), 318, 304, 152. High-resolution mass spectrum (EI), calcd for
C24H17N, 319.13610, found 319.13566.
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CHAPTER 3

INTRAMOLECULAR CONJUGATE AND MARKOVNIKOV ADDITIONS WITH
HETEROCYCLIC OLEFINS

1. Introduction
The first published example of a conjugate addition type reaction was the addition of
diethyl sodiomalonate 2 to diethyl ethylidenemalonate (2, eq 1) reported by Komnenos in
1883.52

Scheme 3.1: Komnenos’ First Conjugate Addition Reaction
Although this is the first example of this class of reaction, the pioneering work was
really done shortly after by the American chemist, Arthur Michael. In general, conjugate
additions (1,4-additions) have been named Michael additions or the Michael reaction because
of the extent of his work. In 1947, Doering and Weil described the base-promoted conjugate
additions of diethylmalonate to 2- and 4-vinylpyridine.53 Thereafter, it was recognized that
vinyl-substituted N-heteroaromatic compounds were potential Michael acceptors. Since,
vinyl-substitued N-heterocycles have been shown to react with a variety of strong and
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moderately strong nucleophiles.

This includes chemistry with amines, alcohols, thiols,

enamines, enolates and other carbanionic species. Very few examples are known involving
weak nucleophiles such as aromatic compounds or alkanes.
Conjugate addition is defined by the Royal Society of Chemistry as a joining reaction
where a nucleophile adds to the beta-carbon of an α,β-unsaturated system (or an activated
carbon-carbon bond) and is synonymous with nucleophilic conjugate addition.

This

definition seems to coincide with the following description for conjugate addition.
Perlmutter states that, “Conjugate addition refers to the addition of any class of nucleophile
to an unsaturated system in conjugation with an activating group, usually an electron
withdrawing group,” and that “Michael addition refers to the addition of carbanions to
unsaturated systems

in conjugation with an activating group or addition of stabilized

carbanions to unsaturated systems in conjugation with a carbonyl group.” 54 In the systems
described below it is clear that the unsaturated olefin is activated by a protonated or doubly
protonated heterocyclic aryl group, with an aryl nucleophile (not an anion). Therefore, the
term “conjugate addition” will be used from here on.
The Klumpp group recently described the superacid-promoted conjugate addition
reaction of vinyl-substituted N-heterocycles.14,55 In these conversions, a series of vinylsubstituted diazines 3 were shown to undergo conjugate addition reactions with the weak
nucleophile benzene (eq 2).55
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Scheme 3.2: Example of Superacid Promoted MA and CA Addition Reactions
It was also observed that Markovnikov-type addition 6 reactions occur with some
isomeric substrates 5 (eq 3) and with azines such as pyridine. 4 It was proposed that the
addition reactions were controlled by the charge distributions in the doubly-protonated
diazines. Conjugate addition tends to be favored when the vinyl-group is at a carbon bearing
a large positive charge, while Markovnikov addition is favored at more negatively charged
carbons, as determined by the calculated NBO charges on doubly-protonated pyrimidine. It
was proposed that the relatively high electron density at the C-5 position allowed for
carbocation formation and the resulting Markovnikov addition.

Conversely, the more

positive ring carbons strongly destabilize carbocation intermediates, while also promoting
conjugate addition with the weak nucleophile benzene. To test this hypothesis, compounds 7
and 9 were reacted in FSO3H-SbF5 in SO2ClF (4:1) at -50 oC (eq 4 and eq 5).
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Figure 3.1: Cold-Temperature 13C-NMR Spectrum of Quinoxaline Dication

Figure 3.2: Cold-Temperature 13C-NMR Spectrum of Quinoxaline Trication
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The low temperature

13

C-NMR spectra of the dication 8 (Figure 3.1) and trication 10

(Figure 3.2) support the predicted superelectrophiles from equations 4 and 5, thus supporting
the hypothesis.
While intramolecular reactions of strong nucleophiles with vinyl-substituted Nheterocycles are known, there are no examples of similar chemistry with aryl nucleophiles.
Given the value of functionalized heterocycles, we have sought to determine if
intramolecular chemistry is possible with weak aryl nucleophiles and vinyl-substituted Nheterocycles.

Moreover, we were interested in determining if the type of addition –

Markovnikov verses conjugate addition – may be correlated to regioisomeric effects and the
type of heterocyclic ring.
2. Results and Discussion
The studies began with the synthesis of several types of heterocyclic substrates. In
planning the synthetic route to these olefins, it was convenient to use the N-heterocyclic
ketone as a synthetic intermediate. The quinoxaline series proved to be exceedingly difficult
to synthesize and many synthetic routes were attempted. Good results had been obtained
from the Grignard reaction with 2-pyridyl and 2-pyrimidyl nitriles to obtain ketones in one
step (see Chapter 1).
quinoxaline series.

Therefore we thought it prudent to create the nitriles for the
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Scheme 3.3: Failed Attempts to Synthesis 2-hydrocinnamoyl-quinoxaline Through
Grignard Chemistry
Three attempts were made to accomplish the synthesis of 2-quinoxaline carbonitrile
(eq 6-8). First, malononitrile and selenium dioxide were dissolved in a minimal amount of
DMSO in a microwave vial for and stirred for 20 minutes until the solution returned to room
temperature forming triselenium dinitrile. Quinoxaline was then added after and the vial
placed in a conventional microwave oven. 56 After an hour at the lowest power setting 6% of
2-quinoxaline carbonitrile was obtain.

The product was isolated and treated with

phenethylmagnesium bromide in diethyl ether at 0oC and stirred overnight. Unfortunately,
no product was observed. Although the nitrile is accessible via this route the reaction is low
yielding and difficult to reproduce due to the lack of a stirring mechanism in a conventional
Zenith microwave oven. More conventional methods were also tried to achieve this nitrile
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using CuCN in pyridine and KCN in DMF and water. In both cases, no product was
observed.
At this point we decided to put the nitrile aside and attempt the Grignard reaction with 2quinoxaline carboxaldehyde (eq 9). The aldehyde was synthesized in good yield. However,
reaction with phenethylmagnesium chloride was unsuccessful.

We then synthesized 2-

acetyl-quinoxaline (eq 10). Aldol condensation with benzaldehyde (eq 11, step 1) afforded
the α,β-unsaturated ketone in quantitative yield. Unfortunately, hydrogenation (eq 11, step 2)
gave a mixture of products and over reduction products that could not be separated by
chromatography. Of all the attempts to synthesize these two ketones, the only successful
route was found through Grignard reaction of phenethylmagnesium chloride with 2quinoxaline Weinreb amide (eq 12, step 4). The amide was synthesized following a patented
procedure but the final Grignard step proved to be extremely low yielding with both
phenethylmagnesium chloride and methylmagnesium bromide, in contradiction to the patent
authors’ claim of high yield.57
Although no good synthetic route was found for the 2-quinoxaline and 6-quinoxaline
ketone derivatives, two methods were found to be useful, direct Stille coupling of a vinyl
stannane (eq 13) and via an Aldol condensation (eq 14). The requisite vinyl stannane 11 was
prepared from 4-phenyl-1-butyne using a published procedure.58 Using PdCl2, the Stille
coupling provided derivatives of pyridine, pyrimidine and quinoxaline.
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Scheme 3.4: Failed Attempts to Synthesis 2-hydrocinnamoyl-quinoxaline Through
Conventional Methods

Scheme 3.5: Stille Coupling Reaction Used to Obtain Olefins
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An alternative synthetic route was developed by fellow group member, Yiliang
Zhang, using an Aldol condensation, reduction, and Wittig reaction (eq 14). However, this
synthetic strategy was somewhat limited by the lack of availability of acetyl-substituted
heterocycles.

Scheme 3.6: Aldol Condensation, Reduction, and Wittig Reaction to Olefins
In accord with our previous studies, superacid-promoted reactions of vinyl-substituted
diazines provides the conjugate addition products from pyrimidine, pyrazine, and quinoxaline
substrates (eq 15-17). The Klumpp group had previously shown that 2-vinylpyrimidine
undergoes conjugate addition with benzene in the CF3SO3H promoted reaction.55 Thus, the
intramolecular reaction provides the tetralin derivative 13 in good yield from substrate 12.
Vinyl-substituted pyrazines and quinoxalines have also been shown to undergo conjugate
additions with benzene, and likewise, both systems give the expected tetralin products (15
and 17) from the corresponding olefins, 14 and 16 (reaction shown in eq 16 was performed
by Yiliang Zhang).
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Table 3.1: Superacid Promoted Conjugate Addition Reactions
In our previous studies related to intermolecular chemistry, it was shown that 2vinylquinoxaline gives a product from conjugate addition, while 6-vinylquinoxaline gives the
product from Markovnikov addition.55

Intramolecular chemistry follows the same

regioisomeric pattern. As described above, compound 16 provides the conjugate addition
product (17) by cyclization (eq 17). With substitution at the 6-position, the Markovnikov
addition product (19) is formed as the only major product (eq 18). A similar transformation
was attempted with the 5- substituted pyrimidine (20), but this gave a complex product
mixture from which no major products could be isolated (eq 19). An indane product (22)
was formed from the reaction of the pyridine derivative (21, eq 20). This Markovnikov-type
cyclization is consistent with previous results involving intramolecular reactions with 2-
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vinylpyridine. Interestingly, the superacid-promoted reaction of 21 also gave a significant
amount of 2-isopropenylpyridine (23) as an unexpected product (identified by GCMS).

Scheme 3.7: Superacid-Promoted Conjugate Addition of 6-quinoxaline System

Scheme 3.8: Superacid-Promoted Markovnikov Additions
It is proposed that the intramolecular reactions occur by two basic pathways:
Conjugate and Markovnikov additions (Scheme 1). The pKa values of methylpyrazine have
been estimated to be 1.45 and -5.25, so it may be assumed that the ring nitrogen atoms are
fully protonated in excess superacid (CF3SO3H, Ho -14.1).* Similar acid-base chemistry with
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the pyrimidine and quinoxaline systems lead to the dicationic intermediates, such as 24,
which trigger the conjugate addition. This involves nucleophilic attack by the phenyl group
followed by protonation of the olefinic carbon. As described above, carbocation formation is
inhibited in this case, because protonation at the terminal carbon would generate a highly
destabilized carbocation (25).

With the 6-position isomer, the carbocation site may be

formed because there is relatively high electron density at the heterocyclic ring carbon.
Thus, the diprotonated quinoxaline (26) may be protonated at the olefin and the carbocationic
intermediate (27) is formed, leading to Markovnikov-type addition. Despite the formation of
a tricationic ion (27), the carbocation site is adjacent to a ring carbon with high electron
density and the three positive charges are fairly well separated. In the case of compound 21,
the carbocation may also form adjacent to the pyridinium ring, leading to dication 28. The
Markovnikov addition through the carbocation leads to indane 30. Regarding the formation
of, 1-isopropenylpyridine (29), it may be explained by the cleavage of the propyl group to
give ion 29 and the benzyl cation. It is not presently clear why benzyl cleavage only occurs
in the case of the pyridine substrate (21).
Based on the above results, we studied another structure type incorporating the 2vinyl-1,1’-biphenyl functionality (Scheme 3.9).

The initial synthetic strategy was to

synthesize ketones 31, 33, and 35, followed by olefination to the desired starting materials.
Ketones 31, 33, and 35 were prepared by the reaction of the
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Figure 3.3: Reaction Mechanisms
N-heterocyclic nitrile and 2-biphenylmagnesium bromide. When standard Wittig conditions
failed, Peterson olefination conditions were used to convert 31, 33, and 35 to their
corresponding olefins (32, 34, and 36). Although ketone 35 was prepared in good yield,
olefination to compound 36 was unsuccessful on our initial attempt.
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Scheme 3.9: Synthesis of Biphenyl Olefins
We were hoping that by adding the ring to the ethylbenzene tether we could stabilize the
carbocation at the olefinic carbon, eliminating the possibility of benzyl cleavage. Indeed, in
the presence of triflic acid, compound 32 (eq 24) undergoes Markovnikov-type addition to
give compound 37 in quantitative yield. Compound 34 undergoes conjugate addition to give
compound 38 (eq 25).
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Scheme 3.10: Superacid-Promoted Additions of Biphenyl Olefins
For these systems (eq 24 and 25) as well as in the case of the quinoxaline system, the
mechanism of addition correlates with calculated NBO charges of the ring carbons or, in the
case of the pyrazine substrate 34, observed intermolecular chemistry: conjugate addition is
favored at positively charged sites while Markovnikov addition is favored at more negatively
charged sites.
3. Conclusions
In summary, we have found that intramolecular conjugate addition may be accomplished
with aryl nucleophiles and olefinic N-heterocycles.

The chemistry follows similar

regioisomeric patterns found in our earlier intermolecular studies. Conjugate additions tends
to be favored at ring positions of relative low electron density (positive charge) while
Markovnikov addition tends to be favored at positions of relatively high electron density.
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4. Experimental
General.
All reactions were performed using oven-dried glassware under an argon atmosphere.
Trifluoromethanesulfonic acid was freshly distilled prior to use. All commercially available
compounds and solvents were used as received. 1H and

13

C NMR were done using either a

500 or 300 MHz spectrometer; chemical shifts were made in reference to NMR solvent
signals. Low resolution mass spectra were obtained from a gas chromatography instrument
equipped with a mass-selective detector, high-resolution mass spectra were obtained from a
commercial analytical laboratory (electron impact ionization; sector instrument analyzer
type). Triflic acid may also be recovered and recycled quantitatively. 16

Preparation of Olefins, General Method A.
The heterocyclic bromide (0.5 mmol) is combined with palladium(II) chloride (2.0 mg, 0.01
mmol), copper iodide (3.8 mg, 0.02 mmol), cesium fluoride (151.9 mg, 1.0 mmol) in a dry 10
mL round bottom flask in a glove box. (2.74 mL, 0.65 mmol) of a 0.1 m solution (100 mg/1
mL)of tri-n-butyl(4-phenylbut-1-en-2-yl)stannane in DMF was added followed by tri-tertbutylphosphine (0.020 mL, 1 M in toluene) and the mixture was heated to 100 oC. This
stirred overnight, maintaining temperature. After this time the mixture is cooled to 0 oC in an
ice bath and trimethylaluminum (2.5 mL, 2.0 M in toluene) is added dropwise over 5 minutes
(vigourous!) and the mixture is stirred for 3 hours. After this time the mixture is poured over
NaOH (10 mL, 1 M aqueous) and swirled until gas evolution ceases. The product mixture is
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partitioned between dichloromethane and water. The aqueous phase is subjected to two
extractions with dichloromethane and the combined organics are washed with water (2x) and
NaCl brine (2x). After drying the solution with anhydrous Na 2SO4, the solvent is evaporated.
The product may be purified by column chromatography (silica gel, ethyl acetate/hexane).

Preparation of Biphenyl Magnesium Bromide General Method B.
Magnesium turnings (3.0 mmol, 0.73 g) were dried in a 50 mL round bottom flask in an oven
for 1 hour to dry. After cooling, 10 mL anhydrous diethyl ether was added and the mixture
was stirred under argon gas at room temperature. 2-bromobiphenyl (2.0 mmol, 0.209g) was
added followed by a flake of iodine. The flask was fitted with a reflux condenser then heated
via heat gun to initiate the reaction (indicated by bubbling of magnesium and a color change
from orange to clear). The mixture was allowed to stir for 1 hour at ambient temperature
then used in the Grignard reaction step.

Grignard Reaction with N-Heterocyclic Nitrile, General Method C.
Biphenylmagnesiumbromide (0.3 M in diethyl ether, 10 mL) was cooled to 0 oC and a
solution of 2.0 mmol of the nitrile in 10 mL diethyl ether was added slowly. The solution
was allowed to warm to room temperature and stirred overnight (12 hours). After this time
the reaction was quenched with 6.0 M HCl and stirred for one hour. The aqueous layer was
made basic (ca. pH 8) by addition of 10 M NaOH, and the mixture is partition in a separatory
funnel. The aqueous layer is extract twice with ethyl acetate, the combined organic extracts
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are washed with water and then brine, and the solution is dried over anhydrous sodium
sulfate.
Olefination of Ketones, General Method D.
Isolated ketones from General Method C were dissolved in 15 mL anhydrous diethyl ether
at room temperature under argon gas. 4.0 equivalents of TMSCH2MgCl (1 M in THF) was
added and the solution was heated to 45 oC. The solution stirred at reflux overnight (12
hours) then cool to 0 oC.

5 mL of concentrated HCL was added slowly (extremely

vigourous) and then heated to 70 oC and stirred for an additional 12 hours. The reaction
mixture is then cooled and made basic (ca. pH 8) with 10 M NaOH, partitioned in a
separatory funnel. The aqueous layer is extract twice with ethyl acetate, the combined
organic extracts are washed with water and then brine, and the solution is dried over
anhydrous sodium sulfate.

Cyclization of Olefins, General Method E.
The heterocyclic olefin (~0.2 mmol) is dissolved in 1.0 mL dichloromethane and is cooled to
0 oC. 0.5 mL of triflic acid is added dropwise and the mixture is stirred for 9 hours at this
temperature. The mixture is poured over ca. 5 g of ice and 50 mL CHCl3. The aqueous layer
is then made basic (ca. pH 8) by addition of 10 M NaOH, and the mixture is partitioned in a
separatory funnel. The aqueous layer is extract twice with CHCl3, the combined organic
extracts are washed with water and then brine, and the solution is dried over anhydrous
sodium sulfate. Alternative method E1: The heterocyclic olefin (~0.2 mmol) is dissolved in
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1.0 mL dichloromethane and 0.5 mL of triflic acid is added dropwise. The mixture is heated
to 60 oC and is stirred for 9 hours at this temperature.

2-(4-phenylbut-1-en-2-yl)pyridine (11).

Using general method A, 2-bromopyridine

(0.079g, 0.5 mmol) gives compound 11 (0.029g, 0.14 mmol, 28%), isolated as a clear, light
yellow liquid, Rf = 0.55 (5:1 hexane:ethyl acetate). 1H-NMR (CDCl3, 500 MHz) δ 2.86-2.89
(m, 2H), 2.98-3..01 (m, 2H), 5.31 (d, J=3.6, 1H), 5.79 (s, 1H), 7.20-7.25 (m, 3H), 7.28-7.32
(m, 3H), 7.51 (td, J=1.0, J=8.0, 1H), 8.69 (dt, J=1.8, J=15.5, 1H), 8.64 (ddd, J=0.9, J=1.8,
J=4.8, 1H)

13

C-NMR (CDCl3, 125 MHz) δ 34.8, 35.6, 115.5, 120.5, 122.2, 125.8, 128.3,

128.5, 136.5, 142.1, 147.5, 148.9, 158.3.

2-(4-phenylbut-1-en-2-yl)pyrimidine (2).

Using general method A, 2-bromopyrimidine

(0.0795g, 0.5 mmol) gives compound 2 (0.0475g, 0.23 mmol, 45%), isolated as a clear,
yellow liquid, Rf = 0.32 (5:1 hexane:ethyl acetate). 1H-NMR (CDCl3, 500 MHz) δ 2.92-3.05
(m, 4H) 5.53 (s, 1H), 6.51 (s, 1H), 7.16-7.23 ( m, 2H), 7.27-7.33 (m, 4H), 8.78 (s, 2H).

13

C-

NMR (CDCl3, 125 MHz) δ 34.8, 35.0, 119.1, 120.2, 125.8, 128.3, 128.6, 142.2, 146.4, 156.7,
165.7.
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2-(4-phenylbut-1-en-2-yl)quinoxaline (6). Using general method A, 2-bromoquinoxaline
(0.1045g, 0.5 mmol) gives compound 6 (0.0685g, 0.2 mmol, 52%), isolated as a clear,
colorless liquid, Rf = 0.37 (5:1 hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) δ 2.94-

3.16 (m, 4H), 5.61 (s, 1H), 6.02 (s, 1H), 7.21-7.34 (m, 5H), 7.74-7.80 (m, 2H), 8.11 (d,
J=1.4, 1H), 8.13 (d, J=1.6, 1H), 9.14 (s, 1H).

13

C-NMR (CDCl3, 125 MHz) δ 34.9, 35.3,

118.6, 125.9, 128.4, 128.5, 129.0, 129.5, 129.7, 130.1, 141.3, 141.8, 141.9, 143.3, 146.1,
152.7.

6-(4-phenylbut-1-en-2-yl)quinoxaline (8). Using general method A, 6-bromoquinoxaline
(0.2828g, 1.4 mmol) gives compound 8 (0.1162g, 0.44 mmol, 33%), isolated as a yellow
resin, Rf = 0.27 (9:1 hexane:ethyl acetate). 1H-NMR (CDCl3, 500 MHz) δ 2.85-3.01 (m, 4H),
5.30 (d, J=0.9, 1H), 5.58 (s, 1H), 7.93 (dd, J=1.9, J=8.8, 1H), 7.21-7.33 (m, 5H), 8.11 (d,
J=8.8, 1H), 8.17 (d, J=1.5, 1H), 8.87 (d, J=12.4, 2H). 13C-NMR (CDCl3, 125 MHz) δ 34.7,
37.1, 115.5, 126.0, 128.4, 128.43, 129.0, 129.3, 141.5, 142.7, 143.2, 144.3, 145.2, 146.5.
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2-(1,2,3,4-tetrahydronaphthalen-2-yl)pyrimidine (4).

Using general method E, 2-(4-

phenylbut-1-en-2-yl)pyrimidine 2 (0.0483g 0.23 mmol) gives compound 4 (0.0411g,
0.20mmol, 85%), isolated as a clear liquid, R f = 0.22 (2:1 hexane:diethyl ether).

1

H-NMR

(CDCl3, 500 MHz) δ 2.03-2.11 (m, 1H), 2.36-2.39 (m, 1H), 2.96-3.13 (m, 2H), 3.18-3.47 (m,
3H), 7.14-7.21 (m, 5H), 8.75 (d, J=4.9, 2H).

13

C-NMR (CDCl3, 125 MHz) δ 28.8, 29.5,

34.4, 43.8, 118.8, 125.7, 125.7, 128.4, 128.9, 129.2, 136.2, 136.2, 157.1, 173.7.

2-(1,2,3,4-tetrahydronaphthalen-2-yl)quinoxaline (7).

Using general method E, 2-(4-

phenylbut-1-en-2-yl)quinoxaline 6 (0.0379g, 0.15 mmol) gives compound 7 (0.0217g, 0.84
mmol, 57%), isolated as a dark yellow resin, R f = 0.25 (7:1 hexane:ethyl acetate). 1H-NMR
(CDCl3, 300 MHz) δ 2.12-2.26 (m, 2H) 2.98-3.51 (m, 5H), 7.18 (s, 4H), 7.72-7.81 (m 2H),
8.09-8.14 (m, 2H), 8.87 (s, 1H).

13

C-NMR (CDCl3, 75 MHz) δ 29.1, 29.4, 34.9, 125.8,

126.0, 129.0, 129.1, 129.2, 130.0, 135.8, 135.9, 141.6, 145.0, 160.0.
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6-(1-methyl-2,3-dihydro-1H-inden-1-yl)quinoxaline (9). Using general method E, 6-(4phenylbut-1-en-2-yl)quinoxaline 8 (0.0495g, 0.19 mmol) gives compound 9 (0.0309g, 0.12
mmol, 22%), isolated as a cloudy, colorless resin, Rf = 0.20 (7:1 hexane:ethyl acetate).

1

H-

NMR (CDCl3, 500 MHz) δ 1.84 (s, 3H), 2.31-2.57 (m, 2H), 2.88-3.07 (m, 2H), 7.08-7.24 (m,
4H), 7.69 (dd, J=2.0, J=8.9, 1H), 7.94 (d, J=1.8, 1H), 8.03 (d, J=8.9, 1H), 8.83 (s, 2H).

13

C-

NMR (CDCl3, 125 MHz) δ 27.3, 30.5, 43.7, 52.5, 124.2, 124.8, 126.0, 126.9, 127.1, 129.0,
130.4, 141.7, 142.8, 143.5, 144.4, 150.0, 151.7.

[1,1'-biphenyl]-2-yl(pyridin-2-yl)methanone (31). Using general method B and C, 2pyridinecarbonitrile (0.2088g, 2.0 mmol) gives compound 31 (0.3498g, 1.3 mmol, 68%)
isolated as a white solid, m.p. 101.1-102.8oC, Rf = 0.23 (5:1 hexane:ethyl acetate). 1H-NMR
(CDCl3, 500 MHz) δ 7.09-7.63(m, 11H), 7.82(td, J=1.0 Hz, J=7.9Hz, 1H), 8.44(ddd,
J=0.9Hz, J=1.7Hz, J=4.8Hz, 1H) 13C-NMR (CDCl3, 125 MHz) δ 123.7, 126.0, 127.1, 128.0,
129.1, 129.4, 130.0, 131.0, 136.3, 136.34, 138.4, 140.7, 141.9, 148.8, 154.6, 198.5.
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[1,1'-biphenyl]-2-yl(pyrazin-2-yl)methanone (33).

Using general method B and C, 2-

pyrazinecarbonitrile (0.2102g, 2.0 mmol) gives compound 33 (0.3152g, 1.2 mmol, 61%)
isolated as a light yellow solid, m.p. 97.5-98.1oC, Rf = 0.26 (5:1 hexane:ethyl acetate). 1HNMR (CDCl3, 500 MHz) δ 7.10-7.24(m, 5H), 7.52(dd, J=1.0Hz, J=7.7Hz, 1H), 7.56(dt,
J=1.2Hz, J=7.6Hz, 1H), 7.65-7.69(m, 1H), 7.75(dd, J=1.3Hz, J=7.7Hz,1H), 8.30(dd,
J=1.6Hz, J=2.4Hz, 1H), 8.43(d, J=2.5Hz, 1H),8.94(d, 1.4Hz, 1H).

13

C-NMR (CDCl3, 125

MHz) δ 127.5, 127.6, 128.3, 129.2, 129.6, 129.8, 131.7, 137.4, 140.3, 142.1, 143.1, 145.1,
146.3, 149.6, 197.5.

2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyridine (32). Using general method D, [1,1'-biphenyl]-2yl(pyridin-2-yl)methanone

31 (0.1653g, 0.6 mmol) gives compound 32 (0.0291g, 0.11

mmol, 18%) isolated as a clear, white resin, Rf = 0.26 (9:1 hexane:ethyl acetate).

1

H-NMR

(CDCl3, 500 MHz) δ 5.53(d, J=18.2Hz, 1H), 6.18(d, J=18.2Hz, 1H), 6.88-7.50(m, 12H),
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8.43(d, J=4.7Hz,1H).

13

C-NMR (CDCl3, 125 MHz) δ 120.0, 121.7, 122.1, 126.5, 127.5,

127.7, 128.2, 129.1, 130.1, 130.9, 135.9, 139.4, 141.1, 141.4, 148.7, 149.2, 157.8.

2-(9-methyl-9H-fluoren-9-yl)pyridine (37). Using general method E (room temperature),
2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyridine 32 (0.0307g, 0.12 mmol) gives compound (0.0307g,
0.12 mmol, >99%) isolated as a cloudy, yellow resin, Rf = 0.31 (9:1 hexane:ethyl acetate).
1

H-NMR (CDCl3, 500 MHz) δ 7.11(s, 3H), 6.66(d, J=8.0Hz, 1H), 7.11(dd, J=5.0Hz,

J=6.6Hz, 1H), 7.29-7.33(m, 2H), 7.37(dt, J=1.7Hz, J=7.7Hz, 1H), 7.41(dt, J=1.0Hz,
J=7.7Hz, 1H) 7.41(dt, J=1.0Hz, J=7.5Hz, 2H), 7.44(s, 1H), 7.46(s, 1H) 7.82(d, J=7.6Hz,
2H), 8.68(d, J=4.1Hz,1H)

13

C-NMR (CDCl3, 125 MHz) δ 24.8, 57.2, 120.2, 121.1, 121.6,

124.4, 127.5, 127.7, 136.2, 140.0, 148.8, 152.4, 163.6.

2-(9,10-dihydrophenanthren-9-yl)pyrazine (38). Using general method E (room
temperature), 2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyrazine 34 (0.0164g, 0.064 mmol) gives
compound (0.0051g, 0.02 mmol, 31%) isolated as a dark yellow resub, Rf = 0.07 (9:1
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hexane:ethyl acetate). 1H-NMR (CDCl3, 500 MHz) 3.34-3.50(m, 2H), 4.47(t, J=5.8Hz, 1H),
7.10(d, J=7.4Hz, 1H), 7.17-7.34(m, 4H), 7.43(t, J=7.2Hz, 1H), 7.62-8.11(m, 4H), 8.81(dd,
J=8.2Hz, J=29.5Hz, 1H) δ 13C-NMR (CDCl3, 125 MHz) δ 29.7, 34.9, 44.6, 122.7, 123.7,
124.3, 127.4, 127.9,128.1, 128.7, 128.71, 134.4, 136.6, 142.5, 144.1, 144.4, 158.2.

2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyrizine (34). Using general method E, [1,1'-biphenyl]-2yl(pyrazin-2-yl)methanone 33 1H-NMR (CDCl3, 500 MHz) δ 13C-NMR (CDCl3, 125 MHz) δ
(0.1190g, 0.46 mmol) gives compound (0.0174g, 0.12 mmol, 15%) isolated as a dark yellow
oil, Rf = 0.14 (9:1 hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) δ 5.17(d, J=1.3Hz,

1H), 6.17(d, J=1.3Hz, 1H), 7.46-7.53(m, 9H), 8.17(s, 1H), 8.18-8.20(m, 1H), 8.31(t,
J=2.1Hz, 1H).

13

C-NMR (CDCl3, 125 MHz) δ 121.4, 126.8, 127.8, 127.83, 128.7, 129.2,

130.2, 130.8, 138.3, 141.0, 142.3, 143.32, 147.1, 150.1.
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CHAPTER 4

SUPERACID-PROMOTED, CYCLODEHYDRATION TO DICATIONS AND
TRICATIONS

1. Introduction
Fluorenes play an important role in organic compounds and the fluorene functional
group can be seen in a wide variety of chemical compounds. As metal ligands, fluorenes
have been shown to increase the catalytic activity of transition metal ruthenium catalysts
through the indenyl effect.23 Much attention has been given to the highly π-conjugated
fluorine system for use as a ligand in transition metal catalysis, as a monomer for polymeric
light emitting diodes, organic superconductor design, bio-sensors, and other organic
electronic devices.58-62 For the development of these organoelectronic devices, optimization
of the charge carrier transport for is usually a key issue and can be mathematically described
in organic materials using Marcus theory (eq 1) where
transfer, (

) is the charge transfer integral,

is the rate constant for electron

is the total Gibbs free energy change for

the transfer reaction, ( ) is the reorganization energy and

is Boltzmann’s constant.59

Rudolph A. Marcus won the Nobel Prize in Chemistry in 1992 for his contributions to
electron

transfer

chemistry.

Although

no

chemical

bonds

are

broken

(or
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formed) in an electron transfer reaction, when an electron is transferred from one molecule to
another the solvent environment does change. 63 Intramolecular, rather than bimolecular
electron transfer reactions, usually take place in the case of organic polymers and the rate of
electron “hopping” is governed by reorganization energy ( ) and the charge transfer integral
(

).59 Designing molecules with rigid, coplanar

-conjugated charge carriers has been

shown to lower the reorganization energy, increase the electronic coupling factor and,
therefore, increase the intramolecular electron mobility. 59 These structural criteria can be met
by incorporating fluerene -conjugated systems such as compound 1.59

(1)

Figure 4.1: Examples of the use of Fluorene Ring Systems in Electron Devices
Many countries are banning the use of inefficient incandescent lamps to meet energy
needs.61 Therefore, the use of white organic light-emitting devices (WOPLED’s) for solidstate lighting has also become an area of interest. Wu and co-workers report highly powerefficient white polymer light-emitting diodes with a single emitting layer based on newly
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synthesized yellow-emitting metallophosphors 2. They claim that because these are low-cost
and large-area WOPLED’s their present work, “will be a key turning point,” and could “turn
WOPLED’s into the power-efficient lighting sources of choice for the future.”61 Interestingly
their compounds incorporate a rigid diarylfluorene structure as well has N-heterocyclic
functionality which acts as a base sight coordinating to iridium, compound 2.
Fluorene itself is obtained from coal tar on the industrial scale or it can be prepared
by dehydration of diphenylmethane.64 Functionalized fluorene derivatives can be synthesized
in a variety of ways.65-68

Scheme 4.1: Rhodium-Catalyzed Dehydrogenative Cyclization
One interesting route is through a rhodium-catalyzed dehydrogenative cyclization (eq 2). 65
In this particular transformation, an RhX active species is formed under oxidative conditions
and coordinates with the amino nitrogen center of substrate 3 amino-directed rhodation form
the five-membered intermediate 4.65 After a second cyclorhodation, the six-membered
intermediate 5 is formed which undergoes reductive elimination to form product 6.65
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Recently, Wang and co-workers established a Brønsted acid-catalyzed Friedel-Crafts
type reaction using triflic acid (eq 3).68 They report that when using a catalytic amount of
TfOH for one minute, they obtained products 8 and 9 in 29% and 70% isolated yield.
However, after allowing the reaction to run for 3 under the same conditions they obtain
product 8 in 91% isolated yield and did not observe product 9.68 Good yields of the multiring derivative 11 was also observed under similar conditions when the indane substrate 10
was used (eq 4). They propose a mechanism in which the benzylic carbocation intermediate
is generated after loss of the HOR group followed an electrophilic aromatic substitution, in
Friedel-Crafts type manner.68 The ring-closure is accompanied by loss of a proton, making
the reaction catalytic.68 They note that in the case of a benzothiazole substituted binary
alcohol, longer reaction time and 4 equivalents were required to produce reasonable yields.
Other than this case, they neglect the N-heterocyclic class stating that, “protonation on the
nitrogen atom on the benzothiazole ring might occur, which tended to inhibition the catalysis
(eq 7).”68

Scheme 4.2: Alternative Synthesis Example
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Scheme 4.3: Brønsted Acid-Catalyzed Friedel-Crafts-Type Reaction
2. Results and Discussion
Throughout this dissertation new reactions have been described in which extended,
multi-ring systems have been achieved via intromolecular cyclizations in the presence of
trifluormethanesulfonic acid. Continuing on this theme, a convenient and efficient synthesis
of N-heterocycle-substituted 9,9-diarylfluorenes is described below including mechanistic
investigation.

As mentioned in Chapter 2, we sought to synthesize a number of N-

heterocyclic ketone substrates 12-14 with biphenyl functionality. These ketones were to be
transformed into
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Figure 4.2: Synthetic Intermediate N-Heterocyclic Ketones
olefins and eventually subjected to treatment with superacid. Looking at the structure of the
ketone, we hypothesized that when treated with triflic acid in dichloromethane, the substrate
would be protonated at the nitrogen base sites and at the carbonyl oxygen. After nucleophilic
attack at the carbonyl carbon by a phenyl carbon, the hydronium ion would leave, the
carbocation would form leave a highly reactive superelectophile. The cation could then be
trapped using a variety of aryl solvents such as benzene, toluene and cumene to give
quarternary, 9-substitued fluorine systems.
To begin the study, ketones 12-14 were synthesized employing a Grignard reaction
with N-heterocyclic nitriles. 2-Biphenyl magnesium bromide was prepared by treating 2bromobiphenyl with magnesium in the presence of iodine in anhydrous diethyl ether. The
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Scheme 4.4: Synthesis of N-heterocyclic Ketones
N-heterocyclic nitrile was then dissolved in diethyl ether and added to the Grignard reagent,
allowed to stir overnight, then treated with 6.0 M HCl to afford desired ketones 12-14 in
good yield (eq 5). Substrate 15 was prepared in a similar manner. 1-Butylimidazole was
treated with excess n-butyl lithium at -78oC for one hour. Nitrile 18 was then added in
solution, stirred overnight, and treated with 6.0 M HCl to give compound 15 (eq 6). 1Benzylimidazole and benzothiozol were treated under the same conditions. Unfortunately,
starting materials were recovered for these reactions and there was no indication of the
formation of products 16 or 17. With ketones 12-15 in hand, we went forth with the reaction
of ketone 12 with triflic acid and benzene (eq 7).
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Scheme 4.5: Reaction of Ketone (12) with Triflic Acid and Benzene
The initial procedure for this reaction was to dissolve the ketone (100 mg) in benzene (2.0
mL) at room temperature and add and extreme excess of triflic acid (2.0 mL) and let the
solution stir for fifteen minutes. These conditions afford the fluorine product 19 in good
yield. To further test the reactivity, we monitored the transformation of 12 in excess triflic
acid by GCMS. We found that the reaction was complete after as little as 5 minutes. Next
we decreased the amount of triflic acid to 10, 5 and 1.1 equavalents and found that the
reaction is complete after 5 minutes the reaction was complete in all cases. We also wanted
to see if the transformation would take place using other acids. We chose the Brønsted acids,
H2SO4, concentrated HCl, trifluroacetic acid, and also BF3 etherate under the following
conditions. 0.030g of the ketone was dissolved in 1.0 mL benzene at room temperature. 1.0
mL of acid was added and the mixture stirred for 15 minutes. The reaction was unsuccessful
using all four of these acids and only starting material was recovered.
Next toluene, cumene, bromobenzene, o-dichlorobenzene, and cyclohexane were
reacted with ketone 12 and triflic acid. The reaction with toluene gave product 20 in
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Table 4.1: Superacid-Promoted Reaction Products with Different Arenes
quantitative yield. The reaction with cumene gave product 21 in low yield (28%). Reaction
of bromobenzene and o-dichlorobenzene both gave the expected fluorine products. In both
cases, however, NMR anaylsis reveals the formation of isomeric products and no isolation
was has been attempted for yield or characterization of 22 or 23. With the reaction of ketone
12 with cyclohexane and triflic acid we expected the formation of product 24 (eq 8). In this
case neither the starting ketone 12 or compound 24 where not observed. We suspect that the
cationic intermediate was formed and lost in the aqueous workup, leaving only cyclohexane.
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Scheme 4.6: Cyclohexane as a Nucleophile
Ketones 13-14 were also reacted with benzene and triflic acid under general conditions to
give product 25-27 in good to excellent yields.

Table 4.2: Superacid-Promoted Reaction Products with Different N-Heterocycles
In order to understand the mechanism of this transformation we wanted to see if we
could observe the dication and trication intermediates by low temperature 13C-NMR and 1HNMR. To accomplish this, the substrate was dissolved in a solution of magic acid (FSO3HSbF5) and SO2ClF at -50oC in an NMR tube. The probe temperature was cooled to -50oC and
the mixtures were analyzed using an external acetone standard. All three systems behaved as
expected. Ketone 12 in the presence of magic acid, deprived of a suitable nucleophile,
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Figure 4.3:
exhibits the

13

13

C-NMR Spectrum of (12) in the Presence of Magic Acid

C-NMR (Figure 4.3) and 1H-NMR spectra in (Figure 4.4). Here we see the

carbocation manifested as the most deshielded carbon peak at 189.97 ppm. The eleven other
aromatic peaks are consistent with the fluorine and pyridine substructure components of the
proposed carbocation intermediate. The proton spectrum for intermediate 29, indicates 13
protons. The peak at 9.03 ppm arises from the presence of the hydronium ion. This may be
from the cyclization or the contamination of sample during preparation. These observations
are consistent throughout the low temperature NMR studies of ketones 13 and 14 with magic
acid. In the proposed mechanism shown below after generation of the superelectrophile 28
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the lower ring of the biphenyl functionality acts as the nucleophile attacking the carbonyl
carbon, facilitating loss of water. This leaves the superelectrophilic

Figure 4.4: 1H-NMR Spectrum of (12) in the Presence of Magic Acid
carbocation intermediate 29 available for a second nucleophilic attack by benzene to form the
flourene derivative 19.
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Scheme 4.7: Proposed Mechanism of Superacid-Promoted Cyclodehydration Reaction
Interestingly, the carbocation of this dication is significantly downfield with respect to the
carbocation of the trication intermediate 30 shown in pyrazinyl system.

Likewise, the

pyrimidinyl carbocation intermediate 31 is significantly downfield from the pyrimidinyl
system, assuming that the most downfield carbon peak for each species is in fact the
carbocation. When examining the

13

C-NMR experimental spectra of compounds 12-13 in

magic acid, a range of peak shifting of the carbocation is observed. Due to enhanced antiaromatic delocalization, there is a decrease in deshielding of the carbocation in different Nheterocyclic systems; pyrazine (177.27 ppm) or pyrimidine (169.79 ppm).
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Figure 4.5:

13

C-NMR Spectra of (13) and (14) in the Presence of Magic Acid
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Figure 4.6: 1H-NMR Spectra of (13) and (14) in the Presence of Magic Acid
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To get a deeper understanding of the observed anti-aromaticity exhibited by these
superelectrophilic intermediates, species 32 was synthesized (eq 9) and the substrate was
dissolved in a solution of magic acid (FSO3H-SbF5) and SO2ClF at -50oC in an NMR tube.
Using the conditions described above, the tricationic intermediate 33 was observed by 1D
and 2D NMR (13C-, 1H-, COSY, HMQC, and HMBC, Figure 4.7-4.10).

Scheme 4.6: Synthesis of 32
The 13C-NMR spectrum of 32 in magic acid should show 10 peaks (9 aromatic peaks
and one down field cationic peak). Experimentally there are 8 aromatic peaks and the one
‘proposed’ cationic peak. Because the tricationic intermediate 33 contains a great deal of
symmetry in its structure it is possible that overlap of one of the aromatic carbons occurs
explaining the missing aromatic peak. The COSY spectrum provided evidence that there are
four groups of four equivalent protons adjacent to each other. HMQC shows proton-carbon
coupling of two different proton sets on the fluorene group. Therefore, carbon peak overlap
occurs accounting for the loss of one carbon peak. In order to differentiate between the
cationic carbon and the three quarternary carbons, we ran HMBC analysis. Using these
methods we were able to fully characterize structure 33 and assign all proton and carbon
peaks including identification of the carbocation at 187.2 ppm. In doing so, we can say that
the carbocation for these types of intermediates are the most deshielded carbon.
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Figure 4.7:

13

C-NMR and 13C-NMR Spectra of 33 in the Presence of Magic Acid
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Figure 4.8: COSY of 33 in the Presence of Magic Acid
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Figure 4.9: HMQC of 33 in the Presence of Magic Acid
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Figure 4.10: HMBC of 33 in the Presence of Magic Acid

84
3. Conclusions.
In summary we have developed a sound synthetic route to N-heterocyclic-substituted
diarylfluorene derivatives via a cyclodehydration reaction.

The products were easily

obtained by column chromatograpy or were occasionally pure enough to characterize in their
crude state. Low temperature

13

C-NMR and 1H-NMR experiments with magic acid lead to

the identification of key mechanistic intermediates of four separate systems. The results
indicate that water is substituted by the biphenyl carbon in the first intramolecular cyclization
step leaving a stable, tertiary carbocation available for attack by an external nucleophile to
give N-heterocyclic substituted diarylfluorenes.
4. Experimental.
Preparation of Biphenyl Magnesium Bromide Method A.
Magnesium turnings (3.0 mmol, 0.73 g) were dried in a 50 mL round bottom flask in an oven
for 1 hour to dry. After cooling, 10 mL anhydrous diethyl ether was added and the mixture
was stirred under argon gas at room temperature. 2-bromobiphenyl (2.0 mmol, 0.209g) was
added followed by a flake of iodine. The flask was fitted with a reflux condenser then heated
via heat gun to initiate the reaction (indicated by bubbling of magnesium and a color change
from orange to clear). The mixture was allowed to stir for 1 hour at ambient temperature
then used in the Grignard reaction step.
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Grignard Reaction with N-Heterocyclic Nitrile, General Method B.
Biphenylmagnesiumbromide (0.3 M in diethyl ether, 10 mL) was cooled to 0 oC and a
solution of 2.0 mmol of the nitrile in 10 mL diethyl ether was added slowly. The solution
was allowed to warm to room temperature and stirred overnight (12 hours). After this time
the reaction was quenched with 6.0 M HCl and stirred for one hour. The aqueous layer was
made basic (ca. pH 8) by addition of 10 M NaOH, and the mixture is partition in a separatory
funnel. The aqueous layer is extract twice with ethyl acetate, the combined organic extracts
are washed with water and then brine, and the solution is dried over anhydrous sodium
sulfate.

Triflic Acid-Promoted Cyclization of Ketones, General Method C.
The heterocyclic [1,1'-biphenyl]-2-ylmethanone (~2.0 mmol) was dissolved in 1.0 mL of
aromatic solvent at room temperature under argon gas flow. 0.5 mL of triflic acid was added
dropwise and the solution stirred for 15 minutes at this temperature. The mixture is poured
over ca. 1 g of ice and diluted with 15 mL CHCl3. The aqueous layer is then made basic (ca.
pH 8) by addition of 10 M NaOH, and the mixture is partitioned in a separatory funnel. The
aqueous layer is extract twice with CHCl3, the combined organic extracts are washed with
water and then brine, and the solution is dried over anhydrous sodium sulfate.
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[1,1'-biphenyl]-2-yl(pyridin-2-yl)methanone (12).

Using general method A and B, 2-

pyridinecarbonitrile (0.2088g, 2.0 mmol) gives compound 12 (0.3498g, 1.3 mmol, 68%)
isolated as a white solid, m.p. 101.1-102.8 oC, Rf = 0.23 (5:1 hexane:ethyl acetate). 1H-NMR
(CDCl3, 500 MHz) δ 7.09-7.62(m, 11H), 7.82(td, J=1.0Hz, J=7.9Hz, 1H), 8.44(ddd,
J=0.9Hz, J=1.7Hz, J=4.8Hz, 1H). 13C-NMR (CDCl3, 125 MHz) δ123.7, 126.0, 127.1, 127.2,
128.0, 129.1, 129.4, 129.8, 130.9, 136.3, 136.34, 138.4, 140.7, 141.9, 148.8, 154.6, 198.5.

[1,1'-biphenyl]-2-yl(pyrimidin-2-yl)methanone (13). Using general method A and B, 2pyrimidinecarbonitrile (0.2086, 2.0 mmol) gives compound 13 (0.4015g, 1.5 mmol, 78%)
isolated as a white solid, m.p. 129.5-130.9 oC, Rf = 0.04 (5:1 hexane:ethyl acetate). 1H-NMR
(CDCl3, 500 MHz) δ 6.96-7.26(m, 6H), 7.38-7.60(m, 3H), 8.48(dd, J=0.8Hz, J=12.5Hz, 1H),
8.48(d, J=10.0 Hz, 2H).

13

C-NMR (CDCl3, 125 MHz) δ δ121.4, 127.3, 127.5, 128.2, 129.3,

129.7, 130.1, 131.8, 137.4, 140.2, 156.8, 162.0, 196.0.
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[1,1'-biphenyl]-2-yl(pyrazin-2-yl)methanone (14). Using general method A and B, 2pyrazinecarbonitrile (0.2102g, 2.0 mmol) gives compound 14 (0.3152g, 1.2 mmol, 61%)
isolated as a light yellow solid, m.p. 97.5-98.1 oC, Rf = 0.26 (5:1 hexane:ethyl acetate). 1HNMR (CDCl3, 500 MHz) δ 7.10-7.29(m, 5H), 7.52(dd, J=1.0Hz, J=7.7Hz, 1H), 7.56(dt,
J=1.2Hz, J=7.6Hz, 1H), 7.67(dt, J=1.4Hz, J=7.6Hz, 1H), 7.75(dd, J=1.3Hz, J=7.7Hz, 1H),
8.30(dd, J=1.6Hz, J=2.4Hz, 1H), 8.43(d, J=2.5Hz, 1H), 9/94(d, J=1.4Hz, 1H).

13

C-NMR

(CDCl3, 125 MHz) δ 127.5, 127.6, 128.3, 129.2, 129.6, 129.8, 131.7, 137.4, 140.3, 142.1,
143.1, 145.1, 146.3, 149.6, 197.5.

(1-butyl-1H-imidazol-2-yl)(4'-methyl-[1,1'-biphenyl]-2-yl)methanone

(15).

1.1

equivalence of n-butyllithium (0.84 mL, 2.5 M in THF) is added to a solution of
butylimidazole (0.261 mL, 2.0 mmol) in 10 mL THF at -78 oC and stirrs for two hours. 4’methyl-2-cyanobiphenyl (0.3865g, 2.0 mmol) was then added and the solution is warmed to
rt and stirs for four hours. Quenching and workup follow general method B exactly. Using
this procedure 15 (0.5897g, 1.8 mmol, 93%), isolated as a yellow resin, R f = 0.15 (5:1
hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) δ 0.96(t, J=7.4Hz, 3H), 1.31(septet,

J=7.7Hz, 2H), 1.70-1.76(m, 2H), 2.32(s, 3H), 4.36(t, J=7.3, 2H), 7.00(d, J=0.8Hz, 1H),
7.08(d, J=0.8Hz, 2H), 7.10(s, 1H), 7.22(d, J=4.6Hz, 2H), 7.43-7.64(m, 4H).

13

C-NMR

(CDCl3, 125 MHz) δ 13.7, 19.7, 21.1, 33.0, 48.3, 125.4, 126.6, 128.3, 128.8, 128.9, 129.6,
130.2, 130.5, 136.6, 138.0, 139.0, 141.4, 143.2, 188.5.
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1-butyl-2-(2-methyl-9-phenyl-9H-fluoren-9-yl)-1H-imidazole (27). Using general method
C, (1-butyl-1H-imidazol-2-yl)(4'-methyl-[1,1'-biphenyl]-2-yl)methanone 15 (0.1081g, 0.34
mmol) and benzene give compound 27 (0.1106g, 0.29 mmol 86%), isolated as a white solid,
m.p. = 136.0-142.0 oC, Rf = 0.08 (5:1 hexane:ethyl acetate). 1H-NMR (CDCl3, 500 MHz) δ
0.52-1.08(m, 7H), 2.38(s, 3H), 3.00(t, J=7.9Hz, 2H), 6.82(d, J=1.2Hz, 1H), 7.08(d, J=1.2Hz,
1H), 7.20-7.41(m, 1H), 7.46(d, J=7.7Hz, 1H), 7.68(d, J=7.7Hz, 1H), 7.75(d, J=7.5Hz, 1H).
13

C-NMR (CDCl3, 125 MHz) δ 21.8, 32.5, 46.2, 61.4, 120/1, 120.2, 126.1, 126.7, 126.9,

127.2, 127.5, 127.9, 128.0, 128.1, 128.4, 129.0, 137.5, 138.0, 140.2, 143.7, 148.0, 148.7,
149.0.

2-(9-phenyl-9H-fluoren-9-yl)pyridine (19). Using general method C, [1,1'-biphenyl]-2yl(pyridin-2-yl)methanone 12 (0.1094g, 0.42 mmol) and benzene gives compound 19
(0.1037g, 0.33 mmol, 77%), isolated as a white solid, m.p. = 166.0-171.0 oC, Rf = 0.41 (5:1
hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) 7.11-7.17(m, 4H), 7.24-7.29(m, 3H),
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7.34-7.37(m, 2H), 7.44(td, J=7.5Hz, J=1.0Hz, 2H), 7.47-7.51(m, 1H), 7.68(d, J=7.6Hz, 2H),
7.85(d, J=7.6Hz, 2H), 7.72-8.74(m, 1H).

13

C-NMR (CDCl3, 125 MHz) δ 67.2, 120.2, 121.5,

121.8, 126.7, 126.8, 127.8, 127.8, 127.9, 128.4, 136.3, 140.5, 149.8, 149.9, 163.8.

2-(9-(p-tolyl)-9H-fluoren-9-yl)pyridine (20). Using general method C, [1,1'-biphenyl]-2yl(pyridin-2-yl)methanone 12 (0.0651g, 0.25 mmol) and toluene give compound 20
(0.0838g, 0.25 mmol, 100%), isolated as a white solid, m.p. = 118.0-124.0 oC, Rf = 0.48 (5:1
hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) δ 2.32(s, 3H), 6.98-7.16(m, 6H), 7.31-

7.51(m, 5H), 7.66(d, J=7.6Hz, 2H), 7.82(d, J=7.2Hz, 2H), 8.71(dd, J=0.9Hz, J=4.8Hz, 1H).
13

C-NMR (CDCl3, 125 MHz) δ 21.1, 66.9, 120.1, 121.4, 121.6, 127.7, 127.71, 127.8, 129.1,

136.2, 140.5, 143.0, 149.8, 150.1, 164.0.

2-(9-(4-isopropylphenyl)-9H-fluoren-9-yl)pyridine (21). Using general method C, [1,1'biphenyl]-2-yl(pyridin-2-yl)methanone 12 (0.0950g, 0.37 mmol) and cumene give compound
21 (0.0677g, 0.19 mmol, 28%), isolated as clear, colorless resin, R f = 0.59 (5:1 hexane:ethyl

90
acetate). 1H-NMR (CDCl3, 500 MHz) δ 1.23(s, 3H), 1.24(s,3H), 2.88(quintet, J=6.9Hz, 1H),
6.99-7.15(m, 6H), 7.33(dt, J=1.2Hz, J=8.1Hz, 2H), 7.42(dt, J=1.1Hz, J=7.5Hz, 2H), 7.48(dt,
J=2.0Hz, J=7.8Hz, 1H), 7.64(d, J=7.7Hz, 2H), 7.82(d, J=7.5Hz, 2H), 8.71(ddd, J=0.9Hz,
J=1.9Hz, J=4.8Hz, 1H). 13C-NMR (CDCl3, 125 MHz) δ 23.9, 33.6, 67.0, 120.1, 121.5, 121.6,
126.4, 126.8, 127.66, 127.69, 136.2, 140.5, 143.1, 146.8, 149.7, 150.1, 164.0.

2-(9-phenyl-9H-fluoren-9-yl)pyrimidine (26). Using general method C, [1,1'-biphenyl]-2yl(pyrimidine-2-yl)methanone 14 (0.0995g, 0.38 mmol) and benzene give compound 26
(0.1110 g, 0.35 mmol, 91%), isolated as a clear, light yellow liquid, R f = 0.55 (5:1
hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) δ 7.04-7.08(m, 2H), 7.14(t, J=4.9Hz,

1H), 7.24-7.49(m, 7H), 7.79(dd, J=7.4Hz, J=19.1Hz, 4H), 8.72(d, J=4.9Hz, 2H).

13

C-NMR

(CDCl3, 125 MHz) δ 68.5, 119.0, 120.0, 126.8, 127.4, 127.5, 127.9, 128.4, 140.7, 145.8,
148.9, 157.1, 172.6.

2-(9-phenyl-9H-fluoren-9-yl)pyrazine (25). Using general method C, [1,1'-biphenyl]-2yl(pyrazin-2-yl)methanone 15 (0.1059g, 0.41 mmol) and benzene give compound 25
(0.0984g, 0.30 mmol, 73%), isolated as a light yellow solid m.p. = 168.2-169.8 oC, Rf = 0.33

91
(5:1 hexane:ethyl acetate).

1

H-NMR (CDCl3, 500 MHz) δ 7.07-7.29(m, 5H), 7.35(dt,

J=1.0Hz, J=7.5Hz, 2H), 7.45(dt, J=0.9Hz, J=7.5Hz, 2H), 7.62(d, J=7.7Hz, 2H), 7.85(d,
J=7.6Hz, 2H), 8.45(d, J=18.5Hz, 2H), 8.64(s, 2H).

13

C-NMR (CDCl3, 125 MHz) δ 65.5,

120.4, 126.6, 127.0, 127.7, 128.0, 128.2,128.5, 140.5, 143.0, 144.3, 145.0, 148.7, 159.8.

pyridine-2,6-diylbis([1,1'-biphenyl]-2-ylmethanone) (32). Using general method A and B
to prepare three equivalents of Grignard reagent and reacting with 2,6-pyridinedicarbonitrile
(0.2582g, 2.0 mmol) gives compound 14 (0.3278g, 1.2 mmol, 37%) isolated as a light yellow
solid, m.p. = 111.2-113.5 oC, Rf = 0.44 (5:1 hexane:ethyl acetate). 1H-NMR (CDCl3, 500
MHz) δ 6.71-6.74(m, 4H), 6.99-7.02(m, 6H), 7.21(dd, J=1.1Hz, J=7.6Hz, 2H), 7.48-7.51(m,
2H), 7.54-7.57(m, 2H), 7.59(d, J=1.4Hz, 1H), 7.61(d, J=1.4Hz, 1H), 7.66(t, J=7.7Hz, 1H),
7.85(s, 1H), 7.87(s, 1H).

13

C-NMR (CDCl3, 125 MHz) δ 125.1, 126.6, 127.0, 127.8, 128.9,

129.1, 129.5, 130.6, 137.0, 140.8, 142.2, 152.4, 197.5.
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APPENDIX A

1

H-NMR AND 13C-NMR SPECTRA OF NEW COMPOUNDS IN CHAPTER 2:
CYCLODEHDRATIONS LEADING TO INDENE PRODUCTS HAVING NHETEROCYCLIC SUBSTITUENTS

99

3-Phenyl-1-(pyridin-2-yl)propan-1-one (9), 1H NMR (CDCl3, 300 MHz)

100

3-Phenyl-1-(pyridin-2-yl)propan-1-one (9), 13C-NMR (CDCl3, 75 MHz)

101

1-(3-Methylpyridin-2-yl)-3-phenylpropan-2-one (10). 1H NMR (CDCl3, 300 MHz)

102

1-(3-Methylpyridin-2-yl)-3-phenylpropan-2-one (10), 13C-NMR (CDCl3, 75 MHz)

103

3-Phenyl-1-(pyrimidin-2-yl)propan-1-one (11), 1H NMR (CDCl3, 300 MHz)

104

3-Phenyl-1-(pyrimidin-2-yl)propan-1-one (11), 13C-NMR (CDCl3, 75 MHz)

105

1-(1-Benzyl-1H-imidazol-2-yl)-3-phenylpropane-1-one (25), 1H-NMR (CDCl3, 500 MHz)

106

1-(1-Benzyl-1H-imidazol-2-yl)-3-phenylpropane-1-one (25),
13

C-NMR (CDCl3, 125 MHz)

107

1-(1-Benzyl-1H-imidazol-2-yl)-3-phenylpropane-1-one (25), 1H-NMR (CDCl3, 500 MHz)

108

1-(1-Benzyl-1H-imidazol-2-yl)-3-phenylpropane-1-one (25),
13

C-NMR (CDCl3, 125 MHz)

109

1-(2,5-Diphenyloxazol-4-yl)-3-phenylpropan-1-one (13), 1H NMR (CDCl3, 300 MHz)

110

1-(2,5-Diphenyloxazol-4-yl)-3-phenylpropan-1-one (13), 13C-NMR (CDCl3, 75 MHz)

111

1-(benzo[d]thiazol-2-yl)-3-phenylpropan-1-one (15), 1H-NMR (CDCl3, 500 MHz)

112

1-(benzo[d]thiazol-2-yl)-3-phenylpropan-1-one (15), 13C-NMR (CDCl3, 125 MHz)

113

3-phenyl-1-(thiazol-2-yl)propan-1-one (14), 1H NMR (CDCl3, 300 MHz)

114

3-phenyl-1-(thiazol-2-yl)propan-1-one (14), 13C-NMR (CDCl3, 75 MHz)

115

3-Phenyl-1-(2-phenylquinolin-3-yl)propan-1-one (27), 1H-NMR (CDCl3, 500 MHz)

116

3-Phenyl-1-(2-phenylquinolin-3-yl)propan-1-one (27), 13C-NMR (CDCl3, 125 MHz)

117

3-Phenyl-1-(pyridine-2-yl)propan-1-one (17), 1H-NMR (CDCl3, 500 MHz)

118

3-Phenyl-1-(pyridine-2-yl)propan-1-one (17).

13

C-NMR (CDCl3, 125 MHz)

119

2-(1H-inden-3-yl)-3-methylpyridine (18), 1H-NMR (CDCl3, 500 MHz)

120

2-(1H-inden-3-yl)-3-methylpyridine (18), 13C-NMR (CDCl3, 125 MHz)

121

2-(1H-indene-3-yl)pyrimidine (19), 1H NMR (CDCl3, 300 MHz)

122

2-(1H-indene-3-yl)pyrimidine (19), 13C-NMR (CDCl3, 75 MHz)

123

1-butyl-2-(1H-inden-3-yl)-1H-imidazole (20), 1H-NMR (CDCl3, 500 MHz)

124

1-butyl-2-(1H-inden-3-yl)-1H-imidazole (20), 13C-NMR (CDCl3, 125 MHz)

125

2,3’-Dihydro-5H-spiro[imidazo[1,2-b]isoquinoline-10,1’-indene] (26),
1

H-NMR (CDCl3, 500 MHz)

126

2’,3’-Dihydro-5H-spiro[imidazo[1,2-b]isoquinoline-10,1’-indene] (26),
13

C-NMR (CDCl3, 125 MHz)

127

4-(1H-inden-3-yl)-2,5-diphenyloxazole (21), 1H NMR (CDCl3, 300 MHz)

128

4-(1H-inden-3-yl)-2,5-diphenyloxazole (21), 13C-NMR (CDCl3, 75 MHz)

129

2-(1H-inden-3-yl)benzo[d]thiazole (23), 1H-NMR (CDCl3, 500 MHz)

130

2-(1H-inden-3-yl)benzo[d]thiazole (23), 13C-NMR (CDCl3, 125 MHz)

131

2-(1H-inden-3-yl)thiazole (22), 1H NMR (CDCl3, 300 MHz)

132

2-(1H-inden-3-yl)thiazole (22), 13C-NMR (CDCl3, 75 MHz)

133

2,3-Dihydrospiro[indene-1,11’-indeno[1,2-b]quinoline (28), 1H NMR (CDCl3, 300 MHz)

134

2,3-Dihydrospiro[indene-1,11’-indeno[1,2-b]quinoline (28), 13C-NMR (CDCl3, 75 MHz)

135

APPENDIX B

1

H-NMR AND 13C-NMR SPECTRA OF NEW COMPOUNDS IN CHAPTER 3:

INTRAMOLECULAR CONJUGATE AND MARKOVNIKOV ADDITIONS WITH
HETEROCYCLIC OLEFINS

136

2-(4-phenylbut-1-en-2-yl)pyridine (11), 1H-NMR (CDCl3, 500 MHz)

137

2-(4-phenylbut-1-en-2-yl)pyridine (11), 13C-NMR (CDCl3, 125 MHz)

138

2-(4-phenylbut-1-en-2-yl)pyrimidine (2), 1H-NMR (CDCl3, 500 MHz)

139

2-(4-phenylbut-1-en-2-yl)pyrimidine (2), 13C-NMR (CDCl3, 125 MHz)

140

2-(4-phenylbut-1-en-2-yl)quinoxaline (6), 1H-NMR (CDCl3, 500 MHz)

141

2-(4-phenylbut-1-en-2-yl)quinoxaline (6), 13C-NMR (CDCl3, 125 MHz)

142

6-(4-phenylbut-1-en-2-yl)quinoxaline (8), 1H-NMR (CDCl3, 500 MHz)

143

6-(4-phenylbut-1-en-2-yl)quinoxaline (8), 13C-NMR (CDCl3, 125 MHz)

144

2-(1,2,3,4-tetrahydronaphthalen-2-yl)pyrimidine (4), 1H-NMR (CDCl3, 500 MHz)

145

2-(1,2,3,4-tetrahydronaphthalen-2-yl)pyrimidine (4), 13C-NMR (CDCl3, 125 MHz)

146

2-(1,2,3,4-tetrahydronaphthalen-2-yl)quinoxaline (7), 1H NMR (CDCl3, 300 MHz)

147

2-(1,2,3,4-tetrahydronaphthalen-2-yl)quinoxaline (7), 13C-NMR (CDCl3, 75 MHz)

148

6-(1-methyl-2,3-dihydro-1H-inden-1-yl)quinoxaline (9), 1H-NMR (CDCl3, 500 MHz)

149

6-(1-methyl-2,3-dihydro-1H-inden-1-yl)quinoxaline (9), 13C-NMR (CDCl3, 125 MHz)

150

[1,1'-biphenyl]-2-yl(pyridin-2-yl)methanone (31), 1H-NMR (CDCl3, 500 MHz)

151

[1,1'-biphenyl]-2-yl(pyridin-2-yl)methanone (31), 13C-NMR (CDCl3, 125 MHz)

152

[1,1'-biphenyl]-2-yl(pyrazin-2-yl)methanone (33), 1H-NMR (CDCl3, 500 MHz)

153

[1,1'-biphenyl]-2-yl(pyrazin-2-yl)methanone (33), 13C-NMR (CDCl3, 125 MHz)

154

2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyridine (32), 1H-NMR (CDCl3, 500 MHz)

155

2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyridine (32), 13C-NMR (CDCl3, 125 MHz)

156

2-(9-methyl-9H-fluoren-9-yl)pyridine (37), 1H-NMR (CDCl3, 500 MHz)

157

2-(9-methyl-9H-fluoren-9-yl)pyridine (37), 13C-NMR (CDCl3, 125 MHz)

158

2-(9,10-dihydrophenanthren-9-yl)pyrazine (38), 1H-NMR (CDCl3, 500 MHz)

159

2-(9,10-dihydrophenanthren-9-yl)pyrazine (38), 13C-NMR (CDCl3, 125 MHz)

160

2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyrizine (34), 1H-NMR (CDCl3, 500 MHz)

161

2-(1-([1,1'-biphenyl]-2-yl)vinyl)pyrizine (34), 13C-NMR (CDCl3, 125 MHz)

176

APPENDIX C

1

H-NMR AND 13C-NMR SPECTRA OF NEW COMPOUNDS IN CHAPTER 4:

SUPERACID-PROMOTED, CYCLODEHYDRATION TO DICATIONS AND
TRICATIONS

177
The spectrum for the following compounds can be found in Appendix B:

[1,1'-biphenyl]-2-yl(pyridin-2-yl)methanone Chapter 4 (12), Chapter 3 (31).

[1,1'-biphenyl]-2-yl(pyrazin-2-yl)methanone Chapter 4( (14), Chapter 3 (33).
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[1,1'-biphenyl]-2-yl(pyrimidin-2-yl)methanone (13), 1H-NMR (CDCl3, 500 MHz)

179

[1,1'-biphenyl]-2-yl(pyrimidin-2-yl)methanone (13), 13C-NMR (CDCl3, 125 MHz)

180

(1-butyl-1H-imidazol-2-yl)(4'-methyl-[1,1'-biphenyl]-2-yl)methanone (15),
1

H-NMR (CDCl3, 500 MHz)

181

(1-butyl-1H-imidazol-2-yl)(4'-methyl-[1,1'-biphenyl]-2-yl)methanone (15),
1

H-NMR (CDCl3, 500 MHz)

182

1-butyl-2-(2-methyl-9-phenyl-9H-fluoren-9-yl)-1H-imidazole (27).
1

H-NMR (CDCl3, 500 MHz)

183

1-butyl-2-(2-methyl-9-phenyl-9H-fluoren-9-yl)-1H-imidazole (27),
13

C-NMR (CDCl3, 125 MHz)

184

2-(9-phenyl-9H-fluoren-9-yl)pyridine (19), 1H-NMR (CDCl3, 500 MHz)

185

2-(9-phenyl-9H-fluoren-9-yl)pyridine (19), 13C-NMR (CDCl3, 125 MHz)

186

2-(9-(p-tolyl)-9H-fluoren-9-yl)pyridine (20), 1H-NMR (CDCl3, 500 MHz)

187

2-(9-(p-tolyl)-9H-fluoren-9-yl)pyridine (20), 13C-NMR (CDCl3, 125 MHz)

188

2-(9-(4-isopropylphenyl)-9H-fluoren-9-yl)pyridine (21), 1H-NMR (CDCl3, 500 MHz)

189

2-(9-(4-isopropylphenyl)-9H-fluoren-9-yl)pyridine (21), 13C-NMR (CDCl3, 125 MHz)

190

2-(9-phenyl-9H-fluoren-9-yl)pyrimidine (26), 1H-NMR (CDCl3, 500 MHz)

191

2-(9-phenyl-9H-fluoren-9-yl)pyrimidine (26), 13C-NMR (CDCl3, 125 MHz)

192

2-(9-phenyl-9H-fluoren-9-yl)pyrazine (25), 1H-NMR (CDCl3, 500 MHz)

193

2-(9-phenyl-9H-fluoren-9-yl)pyrazine (25), 13C-NMR (CDCl3, 125 MHz)

194

pyridine-2,6-diylbis([1,1'-biphenyl]-2-ylmethanone) (32), 1H-NMR (CDCl3, 500 MHz)

195

pyridine-2,6-diylbis([1,1'-biphenyl]-2-ylmethanone) (32), 13C-NMR (CDCl3, 125 MHz)

